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PREFACE
The investigations described in this thesis were 
carried out in the Muirhead Department of Medicine at 
the Royal Infirmary, Glasgow, from 1948 to 1950, during 
tenure of a Hall Tutorial Fellowship in Medicine. The 
clinical observations were made in the wards of the Royal 
Infirmary and at the'Haematological Clinic. I am indebted 
to Professor L.J. Davis for access to the clinical material 
and for guidance during the course of the investigations. 
The withdrawal of most blood specimens, the performance 
of sternal punctures, the estimation of serum iron, and 
the staining of marrow preparations for iron were carried 
out personally, but I am indebted to Dr. S.L. Tompsett, 
biochemist to the Royal Infirmary at the time, for several 
estimations of tissue iron by the ashing technique which 
are recorded in the earlier part of the work. I am also 
most grateful to Mr.J.D. Devlin of the Department for his 
assistance in the photographing of the charts, and in the 
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I N T R O D U C T  I O I .
The work to be recorded was undertaken to assess the 
value of serum iron estimation in the investigation of anaemia 
and as a guide to therapy, use being made of intravenous and 
oral iron tests and demonstration of stainable iron in sternal 
puncture material* With this purpose in view, the following 
studies were undertaken*
(1 ) The reliability of certain chemical methods for 
serum iron estimation was assessed*
(2) The range of normal serum iron concentration was 
determined, and the effect upon it of age, sex, and time of 
day investigated*
(3) Alterations in serum iron as a result of disease 
were observed and changes in concentration followed during 
the course of the illness*
(4) Saccharated iron oxide was investigated as to its 
suitability as an intravenous test substance and intravenous 
and oral iron tests applied to the investigation of anaemia.
(5) Examination of bone marrow biopsy specimens for 
stainable iron was used to supplement the information gained 
from other sources*
It is recognised that the use of radio-active iron is 
probably the best means available for tracing the intricacies
of iron absorption, transport, storage, and utilization. 
Nevertheless the apparatus required is elaborate, and the 
difficulty of obtaining activated iron is considerable# 
Moreover, radio-active iron is unsuitable for routine 
clinical studies, and the recent introduction of saccharated 
iron oxide in a form which can safely be given intravenously 
in therapeutic doses has increased the need for a method of 
assessment of iron balance in the individual patient, so that 
the occasional case of refractory normoblastic anaemia amenable 
to parenteral iron therapy may be identified# Valquist (1944) 
suggested that a standardized oral iron absorption test might 
prove of clinical value, but he was handicapped in its 
development by lack of a suitable substance for measuring 
the rate of disappearance of iron from the blood during the 
time of performing such a test, and by ignorance of the size of 
existing iron stores in the body# Saccharated iron oxide 
itself offered a substance worth investigating as to its 
usefulness for assessing the rate of disappearance of iron 
from the plasma, and, recently, limited studies have indicated 
that stainable iron in sternal puncture specimens is 
approximately representative of total body stores. With a 
reliable method for estimation of the serum iron, and a 
knowledge of the limits of variation in serum iron in health 
and disease, a study of iron balance appeared possible using 
oral iron absorption curves, intravenous iron disappearance
3tests, and demonstration of stainable iron in sternal puncture 
specimens.
All serum iron estimations and the preparation of 
sternal puncture smears for demonstration of iron were carried 
out personally by the writer, fhe results are discussed in 
relation to their usefulness in clinical investigation and to 
the information yielded regarding intermediary iron metabolism. 
It appears possible that a tendency to malabsorption of iron 
exists in a few cases of MidiopathicM iron deficiency and 
may be revealed by low oral absorption curves, but in the 
writer*s experience malabsorption was never sufficient to 
prevent a satisfactory response to oral iron given in 
therapeutic dosage. In refractory normoblastic anaemias 
associated with chronic diseases, alimentary iron absorption 
is normal and stainable iron is often present in the marrow. 
This evidence of iron accumulation suggests that parenteral 
iron is unlikely to have a place in treatment of these 
patients. This opinion is supported by the lack of response 




A SHORT REVIEW OF IRON METABOLISM*
Witten accounts of iron as a therapeutic substance 
appeared in medical literature long before anything was known 
regarding distribution of the element in the body* A 
detailed account of a medicinal preparation of iron was given 
by Monardes (1596), the preparation consisting of iron and 
steel filings steeped in vinegar and subsequently ground 
until an extremely fine suspension was obtained* The author 
gave no clear account of indications for its use, and 
prescribed that the patient ought to be let blood prior to 
its administration* Sydenham (1661) was the first to 
prescribe iron as a specific remedy, and gave an accurate 
account of its usefulness in the treatment of patients with 
chlorosis* He preferred to use the preparation of steel 
filings, but also recommended the use of naturally-occurring 
iron-containing waters* A further account of the clinical 
use of iron was given by Willis (1684)* He hesitated to use 
iron filings in delicate patients lest they cause damage to the 
organs, and often prescribed a solution of ferrous sulphateo 
H© was aware that the latter might prove dangerous if given in 
excess* Absorption of iron from the alimentary canal into
s5
the blood had been considered by Willis as directly responsible 
for the improved colour of chlorotic patients after treatment, 
but it was not until 1746 that iron was discovered by Menghini 
to be a constituent of the blood, and demonstrable in its 
corpuscular elements. The significance of this advance 
was not immediately appreciated, and even in 1789, Cullen 
wrote that he considered it unnecessary to take any particular 
notice of the iron present in the blood, or of how it had 
reached there. Menghini's work he considered had simply 
demonstrated clearly that iron acting in the stomach had the 
power of increasing the appetite and improving the vigour 
of the circulation. During the first half of the nineteenth 
century iron was therefore still being prescribed in many 
diverse diseases. Anaemia was, however, becoming recognised 
as a specific indication for its administration, and already 
a refractory group was being segregated, as is indicated 
by the writings of Pereira (1854) who described the anaemia 
of cancer, renal and cardiac disease as failing to respond to 
iron. Blaud (1 8 3 1) maintained that in chlorotics the 
blood was incapable of fulfilling its functions adequately 
because it was deficient in an essential pigment. This 
colouring matter, the active principle, could be restored 
by giving iron, and the function of the blood thereby improved.
6That the blood iron was reduced in chlorosis was demonstrated 
by Foediseh in 1832. In 1898 came the first account of two 
distinct blood iron fractions when Abderhalden showed that 
there was more iron in the peripheral blood than could be 
accounted for by the haemoglobin iron in red cells. The 
next year, Hasermann demonstrated iron present in nonhaemolysed 
blood plasma, a fact «h ich was confirmed by Fowell in 1915*
The complex history of iron in the blood and tissues was now 
beginning to unfold itself, and the systematic studies by 
Barkan (1925, 1927> 1933) of.the non-haemoglobin iron,and 
his definition of the essential nature of the serum iron 
stimulated further research and led to a more comprehensive 
understanding of intermediary iron metabolism.
The iron present in the serum at any one time is 
an extremely small proportion of the total body iron. Its 
importance from a clinical point of view lies in the fact 
that it is the transport iron of the body, and as such is 
affected by the amount of iron absorbed, stored, utilised, 
and excreted, and must be in equilibrium with the reserve 
stores and the iron of the gastro-intestinal tract, as well 
as with the site of destruction and site of origin of red cell 
haemoglobin. Changes in its concentration consequently 
reflect alterations in the intermediary iron metabolism, and 
although the turnover of iron between a normal man and his
7environment is small, probably less than a milligram daily, 
the internal turnover within the haemoglobin cycle is in 
the region of 25 mgm. daily. Other non-haemoglobin iron 
fractions such as muscle haemoglobin iron and the iron of 
cellular enzyme systems are relatively fixed fractions, 
which are essential for the functioning of cells. As far 
as is known, they are never depleted however great the 
demand for iron by anaemia, pregnancy or growth, and they 
must meantime be regarded as constants in discussing changes in 
non-haemoglobin iron.
Normal human serum contains an average of about 115ug.$ 
of non-haemoglobin iron, the concentration tending to be 
higher in men than in women. The iron is present as a complex 
organic compound with an iron-binding protein, which Cohn 
et al. (1946) have proved to be a [5 - globulin. Normally 
this protein is only 3 0-4 0 $ saturated but at any time iron 
reaching the blood in excess of the total saturation capacity 
is rapidly eliminated from the circulation (Waldenstrom,
1944; Laurell, 1947)* The excess is probably deposited in the 
tissues and such deposition may account for the toxic effects 
associated with massive parenteral administration of iron 
(Holmberg & Laurell, 1945)* The amount of iron binding 
protein and the degree of saturation (i.e. the serum 
concentration) vary in different forms of anaemia, but the
8changes in each show no obvious relationship. The pro­
portion of protein remaining unsaturated probably bears the 
closer relationship to the quantity of iron assimilated and 
stored (Laurell, 1947).
Provided it is in soluble form, iron is absorbed 
throughout the whole length of the alimentary tract, but 
to the greatest extent in the stomach, duodenum and upper 
jejiinum (Hahn et al, 1943; Copp & Greenberg, 1946). Less, 
efficient absorption further down the tract is due, at least 
in part, to increased alkalinity of the environment causing 
the formation of insoluble iron salts (Hahn 1937). Ingested 
iron compounds are broken down in the stomach in the presence 
of hydrochloric acid and iron liberated in an ionized and 
reduced f orm. An acid medium is required to maintain this 
state, and that it may be the state in which absorption 
occurs was shown by the in vitro experiments of Tompsett (1940) 
in which he demonstrated conversion of ferric to ferrous 
iron in pepsdn^hydrochloric acid mixtures, and by the 
observations of Bergeim & Kirch (1949) indicating that iron 
which had been fed in the ferric form was demonstrable 
thirty minutes later in samples of gastric juice in the 
ferrous form. The presence of phytic acid will impair 
absorption owing to the formation of insoluble phytates 
(McCance et al, 1943), while absence of phosphorus, and
pyridoxin deficiency will enhance it to the extent of 
producing haemosiderosis (Cartwright et al. 1949 ). Ascorbic 
aisid raises the amount of iron absorbed when given along 
with iron, but its deficiency in the body has never been 
proved to inhibit iron uptake (Powell, 1944). lederer 
(1 9 4 0) claimed that there is a specific enzyme in the 
stomach which in the presence of hydrochloric acid is 
responsible for liberating iron from organic complexes in 
food.
Once past the intestinal barrier, the iron appears 
in the blood stream and not at all in the lymph channels 
(Moore et al. 1939). That which is not immediately required 
for haemoglobin synthesis is stored in the liver, spleen and 
bone marrow in the closely related intracellular protein 
complexes ferritin and haemosiderin. Parenterally admin- 
instered iron which is ionizable is also largely taken up 
by the parenchymal cells of the liver and spleen, and to 
a small extent in the convoluted tubules of the kidney, but 
unionizable forms are selectively taken up by the reticulo­
endothelial system (Poison, 1928, 1929, 1933; Cappell, 1930; 
Pinch 1950). The deposition of iron normally liberated from 
effete erythrocytes also occurs primarily in the reticulo­
endothelial cells. The ultimate distribution of all forms
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is probably similar. Storage iron in health, comprises 
about 20$ of the total body iron content but is enough to 
replace only about one fifth of the circulating haemoglobin 
(Hynes, 1949). It is possible that administration of large 
amounts of iron parenterally promotes the development of 
specific tissue receptors which may then augment the storage 
capacity (Pinch, 1950).
Under normal circumstances excretion of iron from the 
body is negligible. Even after large amounts of iron 
intravenously the greatest urinary excretions recorded are 
4-4$ (Crawley, 1951, personal communication) and 5$ (Scott 
& Oovan, 1 9 5 1), and of iron liberated by multiple blood 
transfusion or phenylhydrazine induced haemolysis only about 
0.5$ appears in urine and faeces together. Human bile 
contains 0.08 to 0 .4 0 mg.$ and although animal experiments 
indicate that biliary excretion can be increased tenfold 
as a result of haemolysis, the amount of iron accounted for 
in the bile is still less than 3$ of that which has been liber­
ated by red cell breakdown (Hawkins & Hahn, 1944). Mitchell 
and Hamilton (1949) claim that iron in humans is excreted in the 
sweat, but their finding is difficult to accept, because 
the daily loss of 6 .5  mg. which they record exceeds the amount
r i
normally absorbed in that period.
In view of this very limited capacity to excrete 
iron, McCance & Widdowson (1937) observed that if haemo- 
chromatosis is to be avoided, there must be selective 
absorption. Two years later Hahn et al, using radioactive 
iron, demonstrated that in dogs with chronic post-haemorrhagie 
anaemia, the absorption of iron was much greater than in 
normal animals, and Balfour et al-. (1942) showed, in humans, 
that iron absorption is ten to twenty times better when iron 
stores are depleted than it is in health. Control of 
absorption is probably partially effected by a protein 
complex, apoferritin, in the intestinal mucosa. According 
to Granick (19 46a and b) this substance combines with iron 
intracellularly to form a ferric compound, ferritin, which 
is retained as a reserve from which to maintain saturation of 
the mucosal cells with ferrous iron, the form in which 
absorbed iron is passed on from the cells to the serum when 
the concentration of iron there is lowered. Only when the 
ferritin reserve becomes inadequate to maintain mucosal 
saturation is more iron absorbed from the intestinal lumen. 
Fully saturated mucosal cells therefore act as a ’block” to 
intestinal absorption.
This conception of iron metabolism has largely been 
achieved as a result of experimental work in animals, in
vitro experiments, estimation and histological 
demonstration of iron in post-mortem specimens, and 
investigations with radio-active iron in animals and 
humans. Appreciation of the fact that ingestion of iron 
was followed hy a rise in serum iron led to some clinical 
investigations by means of oral iron absorption curves.
Moore et al.(1939a) were able to show that in the same 
subject given the same dosage of iron, similar curves 
could be reproduced, and in his investigations in anaemic 
subjects, obtained higher curves than normal in patients 
with chronic post-haemorrhagic haemoglobin deficiency.
In untreated pernicious anaemia, the curves were flatter 
than normal, but reverted after adequate treatment. Vanotti 
and Delachaux (1946) obtained less consistent results, 
and their findings of some flat curves amongst patients 
with severe iron deficiency led them to the conclusion 
that such a means of investigation was unreliable. Flat 
curves were obtained in patients with chronic infection 
by Cartwright et al. (194-6 ), and they assumed that both in 
infection and in iron deficiency, they might be accounted 
for by rapid diversion of iron from the serum. Interpre­
tation of oral absorption tests was therefore hampered by 
lack of knowledge regarding the rate at which iron was
13
simultaneously disappearing from the blood stream. The 
presence of an iron-binding protein limiting the maximum 
amount of iron which can remain in the blood has already 
been mentioned, but in the literature less attention has 
been paid to the rate at which the bound iron disappears. 
Using chemical methods, Tbtterman (1949) showed a rapid 
disappearance in infection, and various other reports on 
very small numbers of cases indicate that there is also a 
rapid disappearance in haemoglobin deficiency states.
There has been no investigation performed making use of 
combined oral and intravenous iron tests except by Thedering 
(1 9 4 8) who claimed by this means to differentiate a group 
of iron deficiency anaemias in which malabsorption of iron 
could be regarded as a contributory factor in aetiology. 
Powell (1944) stated that, in her experience, resistance 
to oral iron treatment was sometimes due to failure of 
absorption of iron from the alimentary tract. The report 
of Wilkinson and Slack (1949) supports tins view and suggests 
that refractory hypochromic states due to intestinal 
malabsorption of iron are not rare and are amenable to 
parenteral iron therapy. The availability of intravenous 
iron preparations for general use has made more imperative 
the accurate diagnosis of such cases. The elimination 
of others unlikely to respond to either oral or parenteral
14
iron is of equal importance in view of the limited excretion 
of iron from the body and the danger which theortically could 
result from iron accumulation#
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PART III,
RELIABILITY OP SELECTED METHODS 
FOR SERUM IRON ESTIMATION.
TJie circulating non-haemoglobin iron of the blood is 
an organic complex and, since the plasma loses none of its 
iron in the process of clotting, estimation of the iron may 
be carried out on serum as well as on plasma# Use of serum 
has the advantage of avoiding anticoagulants which may 
interfere with colour development during the estimation.
The analytical procedure is first dependent upon digestion 
of the serum with hydrochloric acid in order to release the 
iron from its organic combination. The subsequent aim is to 
form a coloured complex which, by colorometric measurement 
of the colour intensity, permits of quantitative determin­
ation of its iron content on comparison with freshly prepared 
solutions of known strength.
Vannotti and Delachaux (194©) claimed to demonstrate 
four iron fractions. They observed that one iron fraction 
in serum could be split off by dilution of the serum with 
doubly distilled water and subsequent removal of the proteins 
with trichloracetic acid. The weakly acid medium was
16
probably responsible for splitting off this fraction. A 
bigger fraction was obtained by addition to serum of 
hydrochloric acid, the amount of extraction being dependent 
upon the strength of the acid# A third fraction was 
recognizable after ashing of the HC1# filtrate, iron being 
found present in excess of that which could be estimated 
directly in the extract. A fourth fraction completely 
resisted acid extraction and could be isolated in the 
protein precipitate. Hb other workers claim such detailed 
fractionation, but considerable argument has arisen regarding 
the significance of a fraction obtained by Barkan in his 
original work, and designated "easily split-off iron". It 
has since been shown that this is probably an artefact arising 
from oxidation of the prosthetic group of the haemoglobin 
molecule by oxygen released from oxy-haemoglobin by acids.
Its formation can be prevented by conversion of oxy-haemoglobin 
to carboxyhaemoglobin with carbon monoxide (Lemberg & Legge, 
1941). Grimstein and Moore (1949) using radioactive iron 
showed that this appeared at the same rate in the "easily 
split-off” iron as it did in haemoglobin, and concluded that 
the fraction was therefore artificial# There is the 
possibility that a small iron fraction may be derived from 
blood catalase and intra-erythrocytic verdo-haemoglobin, but 
there is no convincing evidence that the latter exists or that
17
degredation of haemoglobin begins within the red cell.
Three reagents are at present in use for estimating 
the serum iron concentration - (1 ) potassium thyocyanate 
(Kennedy, 1927; Moore et al# 1937); (2 ) orthophenanthroline
(Heilmeyer & Plbtner^ 1937; Barkan & Walker, 1940; Tompsett, 
1940 ); (3) potassium ferricyanide (Fitzpatrick & Howells,
1949) In the present work, lompsett's modification of 
the orthophenanthroline technique and Fitzpatrick*s potassium 
ferricyanide method were used for estimation of the serum 
iron. Both methods have the advantage of simplicity, parti­
cularly the latter, which uses fewer reagents and requires 
less time for colour development. In both, the chemicals 
used are reasonably readily obtainable, and can be prepared 
free from iron.
ORTHOPHENANTHROLINE T ECHNIQUB.
All glassware was steeped in dilute hydrochloric 
acid overnight, thoroughly washed in glass-distilled water 
and dried.
Collection of Blood: About 10 cc. of blood was collected
from an antecubital vein in an acid-washed "Pyrex" glass 
test tube, using a stainless steel needle without a syringe. 
After the serum had separated, it was centrifuged, and cell 
free samples thus obtained.
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Reagents Required:
(1) Hydrochloric Acid, 1.2$
(2) Trichloracetic acid, 20$ solution.
(3 ) Sodium acetate solution saturated.
(4) 2.M acetate buffer solution, pH 4.5, prepared
by mixing 90 volumes of 2.M sodium acetate 
and 110 volumes of 2.M acetic acid.
(5) Hydrazine sulphate, 1$ Solution in 2.M
acetate buffer of pH 4.5* This was always 
freshly prepared before use.
(6) Orthophenanthroline, 0.1$ solution in water.
All solutions were prepared with glass-distilled water 
and filtered through Whatman's No.42 filter paper, which 
had previously been steeped in dilute hydrochloric acid, 
washed in glass-distilled water, and dried.
Analytical Procedure: A mixture of 4 ml. of serum and 2ml.
if 1.2$ hydrochloric acid was placed in an incubator at 37°C. 
for 1-J- hours. After cooling to room temperature, the proteins 
were precipitated by addition of 2 ml. of 20$ trichloracetic 
acid solution and the mixture centrifuged. The supernatant 
fluid was passed through a No.42. Whatman filter paper which 
had been washed with dilute hydrochloric acid and distilled 
water and dried. To 4 ml. of the filtrate 1 ml. of 
buffered 1$ hydrazine sulphate solution, 1 ml. of 0.1$ 






Pig. 1. Curves obtained on estimating the iron content 
or serial dilutions of ferrous sulphate of known con­
centration - orthophenanthroline method.
£0
Table 1. Recovery of iron from aqueous ferrous sulphate 
solutions of known iron concentration - orthophenanthroiine 
method.
Sample Iron Content in )ig.$ Difference
No. Calculated estimated
I 50 loj 55 +5
2 100 105)106 +6
3 200 '<2$) 208 +8
4 50 1%) 53 +3
5 200 iiij194 -6
No significant difference between calculated and estimated 
values•
Table 2. Iron content of serum before and after addition 































































No significant difference between "Before + Amount added" 
and "After values".
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were added in that order, mixing after each addition. The 
mixture was placed in an incubator at 3 7°C. for l£ hours, 
and the depth of colour evaluated in a double photocell
A blank was prepared using 4 ml* glass-distilled 
water in place of serum.
A standard curve was obtained by graphing the photo-
Jit
electric readings for serial dilutions of ferrous sulphate 
of known strength. Such curves were reasonably readily 
reproducible (Fig. I) and a composite curve was satisfactory 
as a standard from which to measure the iron content of 
other solutions. The results of recovery experiments on 
solutions of ferrous sulphate in distilled water and of 
ferrous sulphate added to serum are shown in Tables land 2.
From these results it is appreciated that recovery ] 
does not obtain such a very high degree of accuracy. Even j
I
on triplicate estimation the error can be as great as 20$ | 
in very low dilutions but statistical evaluation shows that 
there is no significant difference between the calculated 
and estimated values over the whole range investigated.
Many investigators do not record figures indicative of the 
accuracy with which they can make their estimations, but 
some, e.g. Powell (1944), claim accuracy to within 3$ on 
duplicate readings. When ^ompsett published the method, 
he claimed a maximum error of 12$.
blue and blue-green filters.
Table 3. Effect of moderate haemolysis on serum iron 
coneentration - orthophenanthroiine method.
Sample
No.
Iron content of 
clear serum, ug.?h
Haemolysed specimen Diff­
erenceHb content Iron content
Ug.?b
140) i35)
1 130)137 5 130)lJ4 -3
140) 13b)
100) 103)
2 95)100 8 98)100 0
105) 99)
121) 116)
3 115)117 8 110)112 -5
115) 109)
160) 170)
4 152)155 10 173)177 +22
153) 189)
100) 110)
5 92) 95 15 109)107 +13
89) 102)
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Effect of Haemolysis on Iron Content of Serum: The
quantity of iron in the serum is so very small when compared 
with the iron content of haemoglobin that it is of paramount 
importance to he certain that haemoglobin iron does not 
interfere with the results. Every precaution was taken 
to obtain blood-free samples of serum, but it still remained 
desirable to know just )jow much interference the presence of 
haemoglobin could cause. As the proteins are precipitated 
by addition of trichloracetic acid to the serum, any haemoglobin 
molecules which are present should, theoretically, be removed 
with their iron attached. It is possible, nevertheless, that 
the previous incubation with hydrochloric acid might split 1 
off some haemoglobin iron. Serum from slightly haemolysed 
blood specimens was therefore analysed as to its iron content, 
the haemoglobin concentration being estimated photo-electrically 
in a portion of the same sample. The results showed that up 
to 10 per cent haemoglobin could be present before the serum 
iron level was affected. This represented fairly gross 
macroscopic haemolysis (Table 3). On these findings, it 
can be accepted that a slight degree of haemolysis does not 
significantly interfere with the estimation of the non­
haemoglobin serum iron.
Bgsic Salt Formation: In dealing with such low dilutions
of a metal, the possibility of basic salts forming a fine 
insoluble precipitate, and so interfering with light
24
absorption during photo-electric estimation, had to be 
considered. To eliminate the possibility of formation of such 
a salt, 1 ml. concentrated sulphuric acid solution was added 
at each estimation over a short period* It became obvious 
that there was no change in the results obtained and its 
addition was discontinued*
Accuracy of the Blank; The blank usually gave a reading of 
15-25 ug.$ when compared with distilled water, but was never 
more than 35ug. $. Variation of the blank itself might
therefore have been partly responsible for errors recorded in 
analyses.
POTASSIUM FHRRICYANIDB TECHNIQUE.
Fitzpatrick and Howell*s potassium ferricyanide 
method was also investigated as to its reL iability. Its 




(2) Trichloracetic acid, 20$ (w/V).
(3) Hydrazine sulphate, 1$ (W/V), prepared fresh
before use*











2 3 4 65 7 98 IO
STRENGTH OF IRON SOLUTIONS jjq.°/o
Fig*2* Curves obtained on estimating the iron 
content of serial dilutions of ferrous sulphate 
of known concentration - ferricyanide method.
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All solutions were filtered through Whatman’s No.42 
filter paper which had been washed in acid, rinsed in double 
distilled water and dried*
Analytical Procedure: A mixture of 4 ml* of serum and
2 ml. of 5$ hydrochloric acid was incubated at 37°C. for 1| 
hours* After cooling to room temperature, 2 ml. of 20$ 
trichloracetic acid solution was added to precipitate the 
proteins. The mixture was allowed to stand overnight and was 
then centrifuged. 4 ml. of the supernatant fluid was 
transferred to another test tube, and to this was added 
successively 1 ml. of 1$ hydrazine sulphate solution, 1 ml. 
of potassium ferricyanide solution and 4 ml. of glass- 
distilled water. The material was well mixed after each 
addition. After 15 minutes, the depth of colour was estimated 
in a Spekker Photo-el eetric Absorptiometer, using a 1 cm. 
cell and a Spekker red filter 0R2*
The blank was prepared using 4 ml. of glass-distilled 
water in place of serum*
A satisfactory standard curve was obtained by estimation 
of samples of ferrous sulphate solution of known iron content, 
and in this method also, the curve was easily reproduced (Pig. 
2). Colour development was static between 15 minutes and 
hours from adding the last of the reagents.
Recovery of known quantities of iron from ferrous 
sulphate solutions in water and from serum with ferrous
27
Table 4. Recovery of iron from aqueous ferrous sulphate 
solutions of known iron concentration - potassium ferri­
cyanide method.
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No significant difference between calculated and estimat 
ed values.
Table 5* Iron content of serum before and after addition 





















































No significant difference between "Before + Amount added" 
and "After " values.
\
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Table 6. Comparison of results obtained by orthophenanthrol - 











I 56 60 4
2 109 102 7
3 180 160 20
4 110 115 5
5 203- 196 7
6 90 92 2
7 114 120 6
8 140 132 8
9 138 130 8
10 158 146
12
No significant difference statistically between ortho­
phenanthroiine and ferricyanide'methods.
sulphate added show an error similar to that obtained by 
the orthophenanthroiine method and not statistically 
significant (Tables 4 & 5)* In this method also, haemolysis 
of slight degree caused no interference in estimation of the 
iron content of the serum.
Comparison of Methods. s Analyses of the same sera j
by each method showed very satisfactory agreement, the
I
differences between one method and the other not being | 
statistically significant (Table 6). This satisfactory 
agreement meant that the one method could be substituted for the 
other at any time#
SUMMARY.
Investigation as to the reliability of the ortho­
phenanthroiine and potassium ferricyanide techniques for 
serum iron estimation, and for recovery of iron added to 
water and serum, has shown that consistent results can be 
obtained by both methods, and that these results are closely 
comparable. No interference is caused by the presence of 
small amounts of haemoglobin iron, or by basic salt formation.
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PART IV.
SERUM IRON IN NORMAL INDIVIDUALS 
AND ITS RELATION TO AGE, SEX, AND TIME OP PAY.
The orthophenanthroiine technique of Tompselrb and 
the potassium ferricyanide method of Fitzpatrick have been 
shown to be reliable for estimation of serum iron. Before 
applying the methods to the study of pathological cases, it 
was necessary to establish the range of serum iron levels 
compatible with health.
Material Examined:
For this purpose, estimations of serum iron were made 
on 120 healthy individuals of both sexes, with ages ranging 
from 18 to 69 years. Samples of blood were taken between 
9 and 10 a.m. after a breakfast of tea and toast only. Of 
this group, 6 men and 6 women were followed weekly for 8 
weeks. In 3 men and 3 women, samples of blood were taken at 
short intervals following a substantial meal. In 30 
individuals, samples were taken at intervals during a whole 
day.
Normal Values;
Surveys of normal values for serum iron levels 
have been published by numerous workers. Their results show 
fairly close agreement, in some instances differences possibly 
being due to the method chosen for estimation rather than to
Table 7* Serum iron concentration in normal indiv^ 
iduals as observed by various investigations.
Investigator Mean serum iron value, ug.$
Males. CD h- CD CO *
Fowweather (1934) 125 105
Heilmeyer & 
Pldtner (1937) 126 69
Moore et al (1937) 121 98
Valquist (1941) 142 123
Brochner-
Mortensen (1943) 128 118
Powell (1944) 143 117
Hemmeler (1946) 132 103
Raurfell (1947) 124 108
Rath & Pinch (1949) 106 94
Cartwright & 
Wintrobe (1949) 127 123
Tdtterman (1949) 140 121
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Fig. 3. Distribution of serum iron levels in 
normal people (120 subjects).
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SERUM IRON CONCENTRATION jug./
Pig. 4. Distribution of serum iron levels among 
males of the series. (64 subjects)
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Pig* 5« Distribution of serum iron levels among 
females of the series. (56 subjects)
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the clinical material used. All except Cartwright and Wintrohe
(1949) find a sex difference (Table 7). Ttttterman (1949) after 
making a detailed review of all the figures available, concluded 
that normal values range from 65-180 ug.$ for females and from 
70-210 ug.$ for males. Values of over 200 ug.$ tend to be 
isolated occurrences. Valquist mentioned one such case. 
Tdtterman recorded it in 2 females and 7 males, and indeed 
found levels of up to 298 ug.$ associated with no observable 
clinical abnormality. In the opinion of most authors, these 
very high levels are simply representative of a physiological 
hypersideraemia. Hoyer (1946) did not conform to this belief, 
but gave no reason why he considered such levels pathological. 
The lower border of normality is 60-70 ug.$ but occasional 
values below 60 ug.$ have been found in people not apparently 
ill.
The results obtained in this investigation are presented 
in Pigs. 3, 4 & 5. The group showed a range of 65-220 ug.$. 
Males showed levels of 65-205 ug.^ with a mean of 129 ug.$ , 
while females varied from 60-220 ug.$ with a mean of 113 ug.$. 
The diagrams representing distribution indicate clearly 
that, although the expected range of readings for each sex 
is approximately the same, only about a third of the women 
have levels over 120 ug.^ while nearly two thirds of the men 
exceed this level. The difference is significant 
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Fig. 6. The relationship of serum iron to age in 
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&• 1 • The relationship of serum iron to age in 
normal females (54 cases).
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individual and another, and for the marked sex difference, 
has not yet been satisfactorily explained.
The influence of age on the serum iron;
The effect of age has not often been considered.
Valquist (1941) found that, below the age of 7 years, the serum 
iron level for both sexes was relatively low. It subsequently 
showed a rise until puberty when the sex difference developed 
due to a flattening-out of levels amongst females and a 
continued slight rise amongst males. A fall in old age was 
demonstrated by Albers (1941) and Eckerstrom (1944), both 
workers dealing with groups of mixed sexes.
Analysis of the present material, split into male 
and female groups, showed that there was a tendency for the 
level to fall with increasing age in males (Fig. 6) . This 
was not apparent in females (Fig.7). As the level for males 
was higher than for females in the younger age groups, this 
meant that, with advancing years, the concentration in males 
approximated to the level maintained by females through-out 
adult life. Valquistls observation that sex differences in 
serum iron levels first developed at puberty suggested that 
endocrine function rather than age itself influenced the 
coneentrat ion.
Sex difference in relation to serum iron:
The sex difference was assumed by Heilmeyer & Pldtner 
(1937) and Skouge (1939) to be the result of iron loss due
3 7
to menstruation. If this were true, Valquist expected 
that it should he corrected by administration of oral 
iron to menstrual women. He was, however, unable to raise 
the average serum iron level in a group given intensive 
oral iron treatment and as he was also unable to demon­
strate a higher average in women who had undergone 
hysterectomy, he was of opinion that the sex difference 
was not due to blood loss, but was probably of endocrine 
origin. Albers (1941) and Eckerstrom (1944) found no 
difference in the average serum iron level of post-menopausal 
women and menstruating women. The data of Guthman (1931) * 
Powell (1944), and Dahl (1948), however, revealed a lower 
serum iron level in women during the actual phase of 
menstrual blood loss and Dahl (1948) and Hemmeler (1939) found 
a lower average level for women during their menstrual life 
than for girls just before puberty or for women after the 
menopause. This they regarded as evidence that menstrual 
blood loss was at least in part responsible for lower levels 
in women. They infer that the changes were caused by 
whole blood loss, and do not refer to any possibility 
of endocrine control.
In the present series of females, analysis according 
to whether or not menstruation was occuring at the time 
of making single estimations showed no correlation between 









Fig. 8* Weekly serum iron levels in 6 normal 




Fig. 9. Weekly serum iron levels in b normal men.
curves obtained for six normal women followed weekly 
for 8 weeks do, however, show a distinctive pattern.
This pattern is not evident in 6 men followed in similar 
manner (Fig. 8 & 9). In 4 of the females, the lowest 
values were recorded during the actual period of blood 
loss. In the two others, although the variation was not 
rhythmic in association with menstruation, it was wider 
than that observed in any of the men. In the 6 males, 
fluctuation in level was less marked, and showed no 
constant cyclic pattern.
In interpreting these findings, two factors must be 
borne in mind; firstly,the possible direct effect of blood 
loss in altering the serum iron, and secondly, the possibility 
of endocrine control influencing iron metabolism. All 
workers who note changes in serum iron concentration in 
association with menstruation are agreed that there is a 
reduction in level during the time of menstrual flow. It 
seems unreasonable to attribute this reduction to the blood 
loss, as various workers have shown that when iron stores 
are adequate, there is no immediate change in the serum 
iron following relatively massive haemorrhage, any fall 
being delayed until stores are called upon for blood 
regeneration. This is usually observable about 7-10 days later 
If menstrual blood loss were going to affect the serum iron, 
it would not therefore become apparent until the following
40
week. Moreover, it has been shown that repeated monthly 
bleeding of healthy males in amounts to correspond to 
menstrual blood loss has no effect on the serum iron.
It therefore seems that an endocrine influence, as suggested 
by Valquist (1941), is the more likely controlling factor, 
but further direct proof that such operates in relation 
to the serum iron level in humans is lacking. It is of 
interest in this connection that Shaerer and Rechenberger 
(1948) found an increase in storage iron in men from young 
adult life onwards, and in women not until late middle life, 
while Steenbock et al. (1936) and Rose & Hubbell (1938) 
caused a decrease in iron storage in adult female rats by 
ovariectomy and an increase in storage in immature female 
rats by administration of follicular hormone.
Diurnal variability of senna iron:
In addition to fluctuation in serum iron levels 
from week to week, diurnal variability has often been 
reported. Lower serum iron levels in the evenings were 
reported by Valquist (1941), Hemmeler (1944), Hoyer (1946), 
and Waldenstrom (1946), but Westral (1944) found a rise in 
the evening, and Moore (1936) no consistent directional 
change, although in his series fluctuation was as great 
as 35 ug.#.
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'fable 8. Values for diurnal serum iron levels in 30 
normal people— ug.y.




1 158 163 150 170 70
2 162 150 125 150 37
3 160 159 130 158 30
4 170 157 185 178 28
5 145 120 1.65 145 45
6 206 180 160 187 46
7 176 166 151 170 19
8 159 . 150 152 168 16
9 135 143 140 IjO 6
10. 105 122 90 100 32
11 108 105 130 96 34
12 112 99 100 98 14
13 ±00 90 95 105 15
14 115 105 115 120 15
15 130 100 103 126 30
16 112 116 105 110 11
17 108 100 70 114 44
18 120 144 120 131 24
19 125 145 122 134 23
20 100 120 125 116 25
21 87 95 80 105 25
22 . 103 80 85 102 23
23 100 112 97 . 102 15
24 132 140 150 126 24
25 103 98 88 96 15
26 75 95 90 77 20
27 75 80 90 90 15
28 65 75 85 81 20
29 60 67 90 58 32
30 71 80 70 65 15
After correcting for the difference between individuals 
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Fig,10. Mean diurnal variations in serum iron when 
cases are divided into 3 groups according to the 
height of the morning value.
Group I:- 140 xig.fo and over; Group II:- 80 - 139 ug.$ 
Group III:- 79 ug.fo and under.
Statistical evaluation (by analysis of variance) 
shows no significant difference between the groups.
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In a group of 30 normal individuals on an ordinary 
light diet, the serum iron was estimated at intervals 
during 24 hours* Samples of blood were taken at 9 a.m.,
1 p.m., 9 p*m., and 9 a.m. on the following day* There
was no uniform directional change, (Table 8), but when 
the series was divided into three groups according to 
whether the initial levels were high, average or low, the 
mean curve for each group appeared to be distinctive (Fig. 10). 
Statistical evaluation, however, revealed (by analysis of 
variance) that, after correcting for the difference between 
individuals, there was no significant diurnal variation.
It had appeared that individuals with a relatively high 
morning level showed a fall during the day-time and a rise 
during the night, while those with low initial levels showed 
reverse changes. There was no characteristic directional 
variation in the middle group* A relationship between 
the direction of diurnal variation and the morning serum 
iron level was noticed by Thedering (1949) and attributed 
by him to autonomic influence. Statistical analysis by 
him of all figures previously given by other workers for 
24 hours showed an exactly similar pattern with a variability 
which was just significant. It is doubtful whether division 
of the cases in this manner adds any information of value.










Fig. 11. Variations in serum iron concentration 
foilowing a meal of average iron aontent.
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rhythm, but the direction which the curve appears to follow 
must be dependent upon the point at which the cycle is 
interrupted to obtain the initial specimen.
The influence of diet and control by the liver:
To observe the possible effect that the taking of 
meals may have had during the day, the serum iron level 
was followed more closely after a substantial meal. In 3 
normal men and 3 normal women, it was evaluated immediately 
before and at 1, 3, and 6 hours after a meal containing meat, 
green vegetables and fruit (Pig. 11). No consistent change 
was found, and it was concluded that an average diet does 
not significantly influence the serum iron. Similar 
negligible changes were reported by Heilmeyer & Pltttner, 
(1937), Skouge, (1939), and Moore et al# (1939a).
Waldenstrom (1946) believed that food may nevertheless have 
an indirect effect on serum iron concentration through 
promoting changes in liver function, and he suggested that 
the differences in hepatic metabolism during the hours of 
waking and of eating, as compared with during sleep, may 
provide the explanation of diurnal variation. Pinch et al.
(1950) in discussing the pathophysiology of iron storage, 
state that the ability of the liver to store iron will 
regulate the level obtained in the serum.
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SUMMARY.
In agreement with other workers, the range of 
normal for serum iron concentration has been found to be 
wide, and to show a distinct sex difference. The average 
level for men is 129 ug.tfo and for women 113 ug.$ In women 
menstruation is associated with a decrease in serum iron. 
Present evidence favours this being due to endocrine 
influence rather than to blood loss. In men between 20 
and 65 years, there is a tendency for the serum iron to 
fall with age, a finding that is not observed in women.
It may be masked in women because of the lower levels 
relative to men in the middle-aged group. Endocrine 
influence rather than age itself may again be the more 
important factor in producing this difference. A diurnal 
cycle is observed causing changes in serum iron concentration 
of an average of 25.7 ug.$ within the 24 hours, but the 
variation on the present work is not significant statistically. 
The taking of meals has not been demonstrated as affecting 
the serum iron but the possibility must be considered that 
changes in liver function as a result of its metabolic 
activity in relation to digestion are partly responsible 
for changes in serum iron concentration.
PART V.
SERUM IRON LEVELS IN PATHOLOGICAL CONDITIONS.
SINGLE OBSERVATIONS ON SERUM IRON IN VARIOUS 
TYPES OP ANAEMIA BEEORE TREATMENT.
The range of serum iron levels compatible with health 
having been investigated, attention was given to the changes 
which might be observed in disease. Estimations were made 
on blood samples taken between 9 and 10 a.m., from patients 
with various types of anaemia. The average values obtained 
are shown in Table 9* 3?he results are in agreement with 
most reports published previously in which reasonable numbers 
of cases have been examined.
Iron deficiency anaemia:
In the 69 cases of iron deficiency anaemia, whether 
of idiopathic or post-haemorrhagic type, the serum iron 
concentration was consistently below 63 ug.$ and actually 
exceeded 50 ug.$ only in isolated instances (Pig.12).
Valquist and Lelachaux (1946) argued that reduction of the 
serum iron of the body was the first effect of iron deficiency, 
and might therefore actually precede any clinical symptoms, and 
probably preceded anaemia itself. Reference has already 
been made to the fact that they claimed to isolate 4 non­
haemoglobin iron fractions in serum. It is doubtful whether
Sable 9. Range of serum iron -values in various types 
of anaemia before treatment.





.. ..... .. j
Iron deficiency 59 15- 63 37 !i
Pernicious anaemia 34 34-273 152 j j
Haemolytic anaemia 12 40-302 158 |
Refractory normoblastic 68 32-170 67 |
Toxic states 16 32-145 72 |
Infections (other than 
hepatitis)
18 45- 92 65 |
Neoplastic diseases 34 38-170 65 j
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Fig. 12. Distribution of serum iron levels in 
iron deficiency anaemia (59 cases).
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SERUM IRON uq.%
Fig. Ij. Distribution of serum iron levels in 
untreated pernicious anaemia (34 cases).
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this fractionation had any clinical significance, but they 
maintained that they could demonstrate one factor particularly 
concerned with tissue oxidation* On this basis, they 
explained the rapid response of epithelial lesions in iron 
deficiency when medicinal iron was given to make good that 
deficiency. They described cases, not anaemic, in which 
koilonychia, glossitis or cheilosis were the only pathological 
features which could be indicative of iron depletion, and 
in which oral administration of iron produced immediate and 
steady improvement. This supported their view that tissue 
hyposideraemia could exist apart from iron deficiency 
hypochromic anaemia. 2heir work gives a possible scientific 
background to clinical facts previously recognised. Amongst 
others, Waldenstfom (1938) gave excellent photographs of 
koilonychia, cheilosis, glossitis and oesophageal narrowing 
existing apart from anaemia, and disappearing completely 
after iron therapy.
Pernicious anaemia:
In the 34 cases of pernicious anaemia, serum iron 
values were widely scattered (Pig* 13). The average level 
of 152 ug.$ was much in excess of normal and highly signi­
ficant statistically. The relatively high levels are in 
agreement with results already published. Low levels have
51
Table 10. Serum iron values in pernicious anaemia as 
comparecTwith results published by other investigators.
Investigator Wo. of 
Cases.
kange of serum iron 
concentration, ug.£>
Moore et al. (1939a) 11 147 - 348
Brflchner-Mortensen(193b) 15 135 - 25b
LaureII(I947) 17 113 - 286
Present work 34 34 - 273
Table II. Serum iron concentration in relation to blood 
values in untreated pernicious anaemia.
Fo. Hb.-gm. H.B.C.mills. 
/ c.mm.
P.C.V. Im .c .v . M.C.H.C. Serun
iron
1 6.35 1.54 18 116.9 35.3 273
2 5.2 1.31 16 125.5 31.7 116
3 6.9 1.60 20 125 34 200
4 5.2 1.59 16 100.5 32.5 221
5 4.14 1.10 14 127 27.8 34
6 6.1 1.54 17 110 36.0 230
7 9.94 2.34 28 119.6 35.5 136
8 7.4 2.24 23 103 30 201
9 4.14 1.05 12 114.3 34.5 173
10 4.7 1.42 18 126.7 2b .1 52
11 9.9 2.46 32 132 30.9 150
12 5.33 1.45 16 110.3 32.4 136
13 10.0 2.95 27 92.0 37 *0 143
14 7.6 2.71 28 103*5 2a. 2 91
15 9.3 2.43 29 119.0 32.0 . 267
16 9.3d 2.27 32 141 29.3 105
17 9.93 2.36 32 136 31.1 73
18 8.6 2.85 29 101.5 29.6 61
19 10.5 3.07 30 97.8 35.0 118
20 7.87 1.77 24 135.6 32.8 180
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not been so frequently observed as in this work and as they 
have usually been isolated observations in patients who had 
infection or neoplasm in addition to pernicious anaemia, 
they have been excluded from previous series reported.
Laurell’s group of 17 cases is, however, the largest published, 
(Table 10), and it is possible that the bigger number in 
the present series may be responsible for disclosing the 
wider range.
Haemolysis has always been thought partly responsible 
for the raised serum iron in perncious anaemia, and the 
arrested function of the marrow may further raise the level 
by damming back iron that is not needed for blood formation . 
There are no grounds for questioning these theories in 
accounting for the raised results, but it is not clear why 
some cases have distinctly subnormal values. There was no 
relationship between the serum iron value and the degree of 
anaemia as indicated by the haemoglobin and red cell count 
(Table 11). Consistently low levels in ir on deficiency 
anaemia suggested that perhaps the lower concentrations in 
some cases of pernicious anaemia might reflect concurrent 
haemoglobin deficiency. An analysis made of the mean 
corpuscular haemoglobin concentration estimated within the 
same week as the serum iron in 25 cases, suggests that the cases 
with lower levels of M.C.H.C. are those with subnormal serum
iron. (Table 11). The M.C.H.C. is below 30$ in 5 cases and 
all of these have less transport iron than is usual in 
pernicious anaemia. After liver injections they recovered 
without additional iron being given so that iron deficiency 
is not conclusively demonstrated, but findings to be 
discussed later in relationship to stainable marrow iron 
support the possibility that it did in fact exist in mild 
degree.
Haemolytic anaemia:
In the presence of haemolysis the serum iron is 
usually reported as elevated. The report by Powell (1944) 
is exceptional, as her cases all had levels within the 
normal range. She suggested that, in such cases, the 
iron was being removed from the serum for haemoglobin 
regeneration at approximately the same rate as haemoglobin 
breakdown was going on in the reticulo-endothelial cells. 
Simultaneous storage of iron might also be taking place, 
and a raised serum iron level could therefore only be 
expected during • acute haemolytic crises and when 
haemoglobin breakdown exceeded iron utilization and 
storage.
The results of my own investigations are shown in 
Table 12. In cases 1 and 4 haemolysis was certainly 
severe. in cases 2 and 3 , it was of low grade chronic type. 
The relatively lower serum iron levels in the latter two are 
therefore in keeping with the idea that less rapid release 
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cell production cause a smaller increase in the transport 
iron# In Gases 9 & 10, a subnormal serum iron level was 
recorded in spite of the fact that very transitory rises in 
the red cell count following blood transfusions indicated 
that destruction of red cells must have been rapid* Prom 
clinical investigations performed, the haemolysis was regarded 
as probably symptomatic in Case 9, although the existence 
of a primary disease was never established, and secondary 
to lymphosarcoma in Case 10* It is possible therefore 
that some factor in addition to haemolysis was affecting the 
transport iron. In Qase 12 haemolysis was attributable to the 
presence of a high titre of cold agglutinins in the blood. 
Although there was persistent anaemia over the two years 
during which the patient was observed, the haemolysis was 
not at any time acute. The maintained high serum iron 
might therefore have been associated with some disturbance 
of the protein balance connected with the presence of the 
cold agglutinins. An increase in globulins might well be 
the responsible factor* An exact fractionation of the 
plasma proteins was unfortunately not performed, but it is 
well known that an increase in ft -globulins can be associated 
with a high titre of cold agglutination, and, as discussed 
earlier, it is one of the ^-globulins which is responsible 
for binding iron in the serum.
56
Infective, neoplastic & toxic states:
All workers are agreed that infection is associated 
with a reduction in serum iron. Heilmeyer (1937) thought 
that until more was learned regarding the nature of anaemia 
in infection, and the anaemia of neoplastic disease, the 
two should "be regarded as of similar aetiology. Fourteen 
years later, satisfactory discrimination has still not been 
made. In the present work infective, neoplastic and toxic 
states have been dealt with as one group and the distribution 
of serum iron levels obtained in 68 cases is represented 
in Fig.14. The pattern indicates that although hypoferraemia 
predominates it is not so severe as in iron deficiency anaemia.
The reduction in serum iron bore no direct relation­
ship to the severity of the anaemia, and only in isolated 
cases was it associated with haemoglobin deficiency. (Patients 
known to have haemorrhage as a complicating factor were all 
excluded from the series). It was shown by Holmberg &
Laurell (1945), Laurell (1947), and Cartwright & Wintrobe 
(1948) that the reduced serum iron in such conditions 
was associated with a reduction in the iron-binding 
capacity of the serum, but this could not be regarded 
as the limiting factor in determining the iron concentration 
because the reduction in serum iron was proportionately 
greater. Diversion of iron from the plasma
57
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Fig. 14, Distribution of serum iron levels in anaemia 
associated with infective, toxic and neoplastic disease.
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to normal storage depots was demonstrated by Cartwright 
(1946), and in the present work, features of interest in 
relation to such diversion were revealed by intravenous 
iron disappearance curves and staining of marrow smears for 
iron. These will be discussed later# There is no evidence 
to indicate that iron loss by excess excretion can account 
for a reduction in transport iron in such conditions (Schaefer, 
1940).
Infective hepatitis and other liver disorders:
The contrasting behaviour of the serum iron in 
infective hepatitis makes it advisable to consider this 
infection separately# In 6 cases the values recorded were 
83, 159f 261, 200, 112, andl40ug$<> During the first 
week of illness high normal, or even greater values have been 
recorded (Hemmeler,(1946) ; Valquist, 1941; Brdchner- 
Mortensen, 1943; Laurell, 1947)* Hemmeler interpreted 
the finding as being indicative of defective iron excretion, 
but this seems a somewhat fallacious argument in the face of 
the many convincing experiments to show the very limited 
excretion of iron by any route at any time, excretion via 
the biliary tract being no exception, (Hawkins & Hahn, 1944). 
Vannotti and Delachaux (1946) pointed out that deposition of 
iron in the liver was dependent upon the functioning of the 
hepatic parenchyma and reticulo-endothial cells. If the
59
liver cells were damaged by disease they could not be 
expected to deal adequately with iron liberated from normal 
red cell breakdown, and this iron might therefore accumulate 
in the serum. In support of such a theory is their 
finding of normal serum iron values in patients with 
obstructive Jaundice without evidence of intrinsic damage 
to liver cells. Laurell (1947) favoured the theory that the 
regulatory function of the liver is put out of action, 
and that iron stored in liver cells in the form of ferritin 
is released into the serum when these cells are damaged 
during the acute phase of hepatitis. The serum iron- 
binding capacity is reduced during the initial phase, but 
is raised during regression of the infective process, at 
which time the serum iron begins to fall.
Hepatic cirrhosis is associated with low values 
for serum iron and a reduction in iron-binding capacity.
This has been postulated as due to a defect in protein 
metabolism (Laurell, 1947)#
Nephritis and Uraemia:
The results obtained in 9 cases of nephritis 
(included in the main series of refractory anaemias) can 
be considered separately in respect of certain features (Table 
(13.). In these patients the problem immediately arises 




































































1 -H + ■. + + + 1 1 +
Cb ITS o
o O rH o in in in in in
1—1 i—1 rH O' r- CTi cn 00 cr*
X X X X X X X X Xo O O o in O o o in
VO o c— VO nO in £>- H- ■o





H  a CD 
cd 03 -P 
■P CS o 
O H  5m 
EH Pi Pi
in o VO ■^ r O H* CM co o• • • • • • • • •
VO VO in H* in VO f"- H- VO
Ki
o ciTX 
O <D • H U W
pq 3 a
CD p O0



















































CM o O'* in rH O' o in 00
• • • • . • • • •
rn H - CM nO H- nO ~o H- nO
C— CO CTV
volume, plasma proteins, infection and metabolite retention, 
In all these cases, the bone marrow was examined by sternal 
marrow puncture and showed reasonable cellularity, although, 
in some instances, not quite such great activity as would 
normally have been expected to counteract the degree of 
anaemia present. Because any tendency to hypoplasia results 
as a rule in normal or increased serum iron values, owing 
to the transport iron not being removed for use, the low 
concentration in these patients is all the more significant* 
In the acute cases, the serum iron could well be reduced 
owing to infection and hydraemia. In subacute cases, 
hydraemia might again have an effect, but some alteration 
in the balance of plasma proteins might easily upset 
intermediary metabolism. Laurell (1947) showed a reduction 
in the plasma iron-combining power in nephritis, which he 
regarded as possibly due to loss of proteins of all forms 
in the urine. When oedema has disappeared and protein loss 
has diminished, the serum iron might be expected to come up 
to, or even to rise above, normal, if the marrow were at 
the same time becoming hypocellular. The two cases recorded 
with levels of 130 and 150 ug$ were patients with chronic 
renal disease and ■urea retention in whom plasma proteins 
were normal and there was no oedema, but two others with 
similar clinical and biochemical findings had relatively
low levels (Cases 7 & 8). The present numbers are 
insufficient from which to draw definite conclusions, but 
in a paper presented at the Association of Physicians 
Meetings in 1950 evidence was produced that the anaemia of 
nephritis was attributable to toxaemia in the acute stage , 
hypoproteinaemia in the subacute, and hypoplasia of the 
marrow latterly. The changes in serum iron in this short 
series could be explained on a similar basis. There is no 
apparent relationship to urea retention.
Conclusions:
The most striking feature is the consistent and marked 
reduction of serum iron concentration encountered in iron 
deficiency anaemia. This is unfortunately not a specific 
characteristic of iron deficiency alone, but is an early 
finding, although to a lesser degree, in most infective 
conditions, and is also present in toxic and neoplastic 
diseases such as uraemia, leukaemia, lymphad@nma and 
carcinoma. In the presence of severe haemolysis, and in 
many cases of pernicious anaemia, the serum iron is 
unusually high. A low level in pernicious anaemia probably 
indicates the presence of associated iron deficiency. In 
parenchymatous liver disease, the serum iron is raised, while 
in obstructive Jaundice it is normal. In the case of 
nephritis and uraemia, available evidence indicates that
the disturbed iron metabolism is more intimately connected 
with protein imbalance than with nitrogen retention.
SERIAL OBSERVATIONS OF SERUM IRQN CPNCENTRATI ON 
DURING- COURSE OF ILLNESS.
Previous reports regarding the behaviour of the 
serum iron during the course of illness have been based on 
very small numbers of cases observed by numerous different 
investigators. Vannotti and Delachaux (1946) in reviewing 
such findings in relation to hypochromic anaemia stated that 
the serum iron fluctuates during the recovery period, but 
does not return to normal until the haemoglobin concentrat­
ion has been restored. In pernicious anaemia, liver induced 
remission was found to be followed by an early and sudden 
fall in serum iron (Powell, 1944; Houghton & ^oan, 1941) 
this being maintained until red cell and haemoglobin levels 
approached normal. The terminal phases of chronic leukaemia 
and most cases of acute leukaemia were observed by Heilmeyer 
& Plfltner (1937) to be associated with lower serum iron 
values than during more favourable phases of these illnesses. 
The relative lack of systematic follow-up over long periods 
in any group suggested that routine check in a series of 
cases might be informative. In a number of patients the 




Eighteen oases of chronic iron deficiency hypochromic 
anaemia were followed in this manner. Eight of these were of 
idiopathic hypochromic type and showed no evidence of 
pathological blood loss at any time. The remaining ten 
had evidence of chronic haemorrhage, the result of bleeding 
piles, menorrhagia, or occult bleeding from peptic ulcer.
One of the latter group was ultimately found to have 
carcinoma of the colon in addition, but faecal occult blood 
had never given more than a week reaction with benzidine.
In 16 patients, observations were continued for ten to twelve 
weeks, and in the other two, for eight weeks. All patients 
reached normal haemoglobin and red cell levels after 
treatment. In the case of patients on intravenous iron, 
injections were given at 3-4 day intervals, and specimens of 
blood for serum iron estimations taken immediately before 
injections were given. Patients on oral iron had had none 
during the 18 hours prior to taking the blood samples. The 
immediate effects of injection or absorption of iron on serum 
iron levels were therefore eliminated, and the readings could 
be regarded as representative of the basic state of transport 
iron at the time.
The patterns of serum iron response were variable, 


















Serum iron levels during recovery of iron deficiency anaemia.
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fable 14. Blood levels in relation to serum iron response 
in chronic iron deficiency anaemia.
Case
No.








1 51 4.2 1.7 a I.V.
2 53 3.2 1.82 a I.V.
3 40 2.5 0.54 b oral
4 68 5.0 0.50 a . oral
5 60 3.6 0.83 b oral
6 72 4.5 0.80 a * oral
7 49 2.9 0.63 c oral
8 59 3-3 0.59 b oral
9 65 3.9 1.20 a I.V.
10 58 4.0 1.00 a oral
11 52 3.1 . 1.10 c oral
12 44 3.0 1.0 c I.V.
13 ' 63 5.2 0.76 b I.V.
14 ' 70 4.3 1.42 a I.V.
15 61 3.9 0.83 c oral
16 42 3.1 2.00 b I.V.
17 40 2.9 1.71 b I.V.
18 38 3.2 0.92 b oral
* a = remittent rise in serum iron during recovery.
b =: steady rise of serum iron to normal during recovery, 
c = persistence of a subnormal serum iron after reco/ery.
+ I. V. = intravenous treatment with. 200 mgm. iron as 
saccharated iron oxide twice weekly, 
oral = administration of Hersolate tab. 1 t.i.a.
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(a) Seven showed a rise as haemoglobin and red 
cells approached normal, and the level afterwards 
remained within normal limits.
(b) Seven showed a rise at 14-21 days, a fall in 
the subsequent 2-3 weeks, and then a rise to 
normal levels.
(c) Four showed persistence of a low serum iron 
concentration after recovery of a normal blood 
level.
These variable patterns were unexpected and occurred 
irrespective of the route used for iron medication. There 
is no apparent connection between the serum iron concentration 
and the rate of rise of the haemoglobin level .(Table 14). It appears 
however, that it is the patients with relatively high initial 
red cell counts who tend to have the early remittent rise in 
serum iron before it finally attains normal levels. In 
trying to account for these differences, reference might 
be made to certain personal observations on absolute values 
which indicate that iron administration can stimulate 
production of normally sized red cells before making good 
the deficient mean corpuscular haemoglobin concentration. 
Absolute values were estimated twice weekly in 6 patients 
during response to routine oral iron therapy (Table 15)* An 
increase in the average size of the red cells precedes an
Table 1 5 . .  Absolute values during treatment of chronic 
hypochromic anaemia with oral iron.
Oase no. hay of 
treatment
Hb. K.B.O. mill, 
/c.mm.
t5 vJT • U . V •
/■■’
 ^t ri \ ■ nid. • O * J 1 • Vy •
if'.'/v'
~;i n v| r.J • v • 1/ •
cu.
1 1 7.5 3.80 30 25-0 78.9
3 7-5 3.71 31 24.2 33.5
7 8.3 4 .16 35 23-4 34 • 1
14 9.0 4.50 40 22.5 88.0
21 10.6 4.70 42 25.0 89-0
28 11.3 4.52 42 29.8 95.0
35 12.0 4.63 43 27.9 90.9
42 13.2 4.61 42 31.4 91.1
2 1 6.0 3.20 24 25.0 75.0
3 6.2 3.22 24 26.0 74.5
7 6.9 3.21 26 26.1 81.2
10 7.2 3.89 30 26.5 77.1
14 8.2 3-98 32 25.6 c)0.4
21 9.0 4.50 37 24.3 82.2
28 10.2 4.55 40 25.5 87.0
31 10.9 4.60 42 26.9 91.0
35 11.6 4.65 42 27.6 90.2
42 12.8 4.72 43 29.1 91.1
3 1 6.4 3-30 22 29.1 66.6
3 6.0 3.24 20 30.0 61.1
7 6.4 3-36 24 26.6 73.8
10 7.6 3-70 27 26.1 72.9
14 h03' • 4.20 23 28.2 69.0
17 9.0 4.44 34 26.3 78.7
21 9.7 4.50 37 26.2 82.2
24 10.6 4.62 38 27.9 84.4
30 11.9 4.85 42 28.3 36.6
35 12.7 5.00 43 29.5 85.0
33 13.2 4.90 43 j0.7 j4 .9
42 13.4 5.08 43 31.1 8 4.6
4 1 7.7 3.60 28 27.5 77.7
3 7.9 4.02 29 27.2 72.0
7 8.4 4.20 32 26.2 76.1
10 9.1 4*46 36 25.3 30.0
13 9.5 4.50 36 26.4 30.0
17 10.4 4.63 40 26.0 8? .0
20 11.5 4.52 42 28.6 93 *0

















5 1 6.7 3.20 26 25.9 81.2
3 6.6 3-32 26 25.4 80.0
7 7.4 3.90 31 23.8 79.5
11 8.2 4.14 32 25.6 79.7
14 9.1 4.26 35 26.0 62.1
17 9.8 4.30 36 27.2 83.7
21 10.7 4.40 38 28.1 86.3
24 11.3 4.42 40 28.2 90.5
27 12.2 4.36 41 29.7 94-. 3
6 1 8.80 4.00 33 26.7 61.5
4 8.4 4.20 33 25.4 78.5
7 9.0 4.50 35 25.7 77.6
10 9.5 4.72 38 25.0 80. 5
14 10.2 4.81 38 27.0 79.0
18 11.0 4.70 40 27.5 ■ 85.1
21 12.0 5.0 41 29.1 82.0
28 13.2 5.0 42 31.4 85»0
31 13.5 5.2 41 30.4 76.7
38 14.0 5.0 43 32.5 86.0
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improvement in the mean corpuscular haemoglobin concentration 
in several cases and in some instances the production of larger 
red cells is associated initially with an actual reduction 
in mean corpuscular haemoglobin concentration although the 
total haemoglobin increases. The fact that administered 
iron can have its greatest effect at first on the red cell 
bodies and not on the haemoglobin may explain the tendency 
for serum iron concentration to vary in relation to the red 
cell count.
Of the four patients who showed final subnormal 
serum iron concentrations in spite of normal haemoglobin 
and red cell counts, one had a chronic mild conjunctivitis 
and corneal ulceration; one was the patient found later to 
have carcinoma of the colon, and one had liver and spleen 
Just palpable throughout the period of observation. The 
number of cases is small, but the findings suggest that the 
persistence of a subnormal serum iron in a patient thought 
to have a simple haemoglobin deficiency probably indicates 
the presence of some other abnormality.
Repeat estimations of serum iron were made on all 
these patients and on 40 others after the haemoglobin 
deficiency had been corrected and maintenance iron treatment 
continued for 6-8 weeks. The repeat estimation was made 
10-14 days after iron had been stopped. The 4 males in the 
group were discounted, and the average value for the females
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Fig. 16. Distribution of serum iron values in 
Seated iron deficiency anaemia.
was found to be 101 ug.$ as compared with 113 ug.$ for 
normal women. The difference is not statistically 
significant but is bordering on significance (Fig. 16). At 
this stage, haemorrhage could not be regarded as playing 
any major part in reducing iron stores, as any source of 
abnormal bleeding had now been controlled. Neither 
did it seem possible that hyperactivity of the marrow could 
still be present, leading to a drain on serum iron by 
increasing the requirements of iron. It therefore seemed 
that some fundamental disturbance of iron metabolism might 
be persisting in at least a proportion of cases. Fontes 
and Ihivoile (1936) found that in haemoglobin-deficient 
dogs accelerated absorption of iron ceased once the bone 
marrow demands had been met, and that supplementary iron 
given for 6-12 months afterwards was not sufficient to 
replete the iron stores. If this slow accumulation of 
stores exists also in humans, it might well explain the 
tendency to a low normal serum iron after only 6-8 weeks 
maintenance iron therapy. The existence of a primary defect 
in alimentary iron assimilation in "idiopathic” cases might 
be postulated and be regarded as accounting for a relatively 
low serum iron. Further investigations in relation to 
this aspect will be discussed later in connection with oral 
iron absorption tests.
7777 p^ §;UM IRON
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Pig. 17• Serum iron levels during response to treat­








The serum iron level was followed weekly in 3 patients 
with, pernicious anaemia in whom the initial levels were 
relatively high. There was a sudden sharp fall in serum 
iron concentration within a day or two of giving liver*
The concentration then remained low until the blood values 
were approaching normal, at which time the serum iron 
concentration also rose (Fig. 17)* The fall was presumably 
accounted for by the sudden demand for iron for haemopoiesis 
once the haemopoietic principle had been supplied. It 
occurred before the reticulocyte crisis was demonstrable and 
was probably co-incident with the very early change of the 
marrow from megaloblastic to normoblastic erythropoiesis. 
Powell (1944), also observing this early fall in serum iron, 
considered it a useful sign of response to treatment, and 
Houghton and loan (1941) regarded it as a reliable indication 
of effective treatment and one which might demonstrate active 
principle in test liver extracts when an adequate reticulocyte 
response was absent*
In 20 female patients, the serum iron was estimated 
3-6 months after normal counts had been maintained (Fig.18). 
The group is small but the distribution of values agreed 
closely with the distribution for normal women, suggesting 
that iron balance was again normal*
Serum iron














19* Serum iron concentration during the course












Fig, 20.  ^ Serum iron level in relation to white cell count 
during nitrogen mustard treatment of lymphadenoma and
bronchial carcinoma.
Myeloid Leukaemia:
In 2 cases of chronic myeloid leukaemia followed 
during treatment with urethane, the serum iron tended to 
rise as the white cell count fell and the haemoglobin 
concentration mounted. In one of these cases seen in a 
terminal acute phase, during which the white cell count 
suddenly increased and the haemoglobin concentration and red 
cell count fell, the serum iron showed a sharp drop (Fig.19) . 
Cartwright and Wintrobe (1948) found that in chronic leukaemia, 
the serum iron level was usually a low normal, but there was 
often a terminal fall, while in acute leukaemia, the serum 
iron was often low throughout the course of the illness. 
Heilmeyer & Pldtner (1937) had made similar observations 
and maintained that serum iron estimation in leukaemia 
could therefore be of prognostic value.
Lymphadenoma and carcinoma:
In 2 patients with lymphadenoma and two with bronchial 
carcinoma, the serum iron was estimated weekly during and 
after nitrogen mustard therapy (Fig. 20). Initial serum 
iron levels were, in all instances, slightly subnormal, 
but during and immediately after treatment, the levels showed 
a definite rise. Brown and Davis (1950) observed marked 
depression of the marrow produced by nitrogen mustard, this 
hypoplasia being reversible, and most clearly reflected 
in the blood by a fall and subsequent rise in the total white
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cell count* If the white count is used as the index of 
marrow activity in the present cases, it is seen that 
depression of marrow function was associated with a rise in 
serum iron, and that regeneration coincided with a fall.
Several previous reports have attributed normal or slightly 
raised iron levels in hypoplastic anaemia to lack of 
utilisation of iron in the marrow. The present observation 
confirms that this view is justifiable by demonstrating 
that induction of hypoplasia by therapeutic means results in 
an increase in serum iron, while recovery of marrow activity 
is accompanied by a fall.
Uraemia, myxoedema and carcinomas
Two patients with uraemia; two with myxoedema and one 
with widespread metases of earcinoma in the skin from an 
undiagnosed primary site, all had a variable degree of slightly 
hypochromic anaemia. Oral iron was ineffective in producing 
any alteration in the haemoglobin and caused no sustained rise 
in the serum iron concentration. Intravenous iron produced 
a slight rise in serum iron levels as long as it was being 
given, but was equally ineffective in raising the haemoglobin. 
In four of these patients, the marrow smears after iron 
injection showed a considerable amount of iron present, thus 
further demonstrating that iron lack was not a significant 
factor in production of the anaemia. Even once in the marrow, 
the body was apparently incapable of using the iron to increase
haemoglobin production
Conclusions:
The serum iron concentration is apparently directly 
influenced by the degree of marrow activity. It shows a 
sharp reduction when erythropoiesis is suddenly stimulated, 
as at the commencement of liver treatment in pernicious 
anaemia, while a rise follows induced depression of marrow 
activity, such as by nitrogen mustard administration. The 
latter change in serum iron concentration is immediately 
reversed when the marrow again resumes its function. In 
leukaemia the serum iron concentration is lowest vhen 
leukaemic activity is greatest but one can only theorise as 
to whether this means a depression of iron metabolism on 
account of the leukaemia or a drain on transport iron as a 
result of the leukaemic hyperplasia. Whatever the mechanism 
for producing a low serum iron in the chronic toxic and 
neoplastic states it is extremely difficult to counteract 
as is indicated by the very temporary increase in serum iron 
concentration obtained after intravenous iron administration, 
and the fact that the concentration remains low even after 
storage iron is demonstrable histologically in the marrow.
The different behaviour of the serum iron concentration 
during recovery in patients with relatively high and relatively
low initial red cell counts may be connected with, the fact 
that after iron administration the production of new and 
normally sized red cells takes precedence in some instances 
over the production of adequately haemoglobinated red cells.
The clinical usefulness of serial observations is 
small. In hypochromic anaemia, the persistence of a low 
level may be an indicator that some other disease is present. 
In pernicious anaemia, the fall after liver administration 
is undoubtedly an early sign of response, but estimation of 
the serum iron is a cumbersome means of obtaining the same 
information, as becomes obvious with the reticulocyte 
response in the vast majority of cases only a few days later. 
Fall in serum iron as an indication of activity of a liver 
preparation seems an unreasonably indirect method of assay.
In the case of iron deficiency anaemia the occurrence 
of serum iron levels in the lower limits of normal 6—8 weeks 
after normal counts have been attained raises the possibility 
of an abnormality in iron balance still existing. The present 
serial observations give no information as to whether this is 
a defect in absorption or in storage. The finding emphasises 
the necessity for continuance of iron therapy for a prolonged 
time after the haemoglobin level has returned to normal.
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PART 71.
■ INTRAVENOUS IRON PIS APP35ARANCE TESTS.
Such results as are recorded from the use of 
intravenous iron disappearance tests are variable 
(Heilmeyer & Pldtner, 1937; Shouge, 1939; Vanotti &
Delachaux, 1942; Br5chner-Mortensen,1943 a & b; Waldenstrbm, 
1944; Tdtterman,1949; ^hedering,1949)• In these reports, 
the observations were mostly incidental in the course of 
other investigations, although in the later papers they formed 
the main subject of study. Ttttterman applied them in 
investigating the role of iron and vitamin 0 in infection, 
and demonstrated an increased rate of iron elimination from 
the blood in infection. Thedering used them in an attempt 
to assess the function of the autonomic nervous system in 
controlling serum iron levels. He concluded that daily 
fluctuations in serum iron concentration were attributable 
to cholinergic and adrenergic control, and that the intensity 
of autonomic activity at the moment of initiating any 
experimental observation determined the degree of response 
which would be obtained, and whether this response would 
be of positive or negative type. This control influenced 
the course of intravenous and oral iron curves. In a later
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paper (1950) he combined the use of oral and intravenous 
iron curves in the investigation of anaemia, and claimed 
to demonstrate a group of idiopathic hypochromic iron 
deficiency anaemias in which impaired alimentary absorption 
of iron was the primary defect.
Suitability of Substances available for Intravenous Iron 
Tests; Three groups of substances may be considered 
in regard to their properties as test agents for investig­
ating the rate of disappearance of iron from the peripheral 
blood stream; namely, electrolyte iron preparations, radio­
active isotopes of iron, and saccharated iron oxides. In 
considering their usefulness in relation to the investigation 
of patho-physiological processes, it is necessary to appreciate 
the chemical state of the normally-occurring non-haemoglobin 
iron of the blood, and the manner in which iron may be 
expected to leave the blood stream. The earlier views 
that non-haemoglobin iron was all in ferric form were 
questioned by Laurell (1947). Starkenstein & Weden (1928) 
had shown that when ferrous iron was added to whole blood it 
was rapidly oxidised to the ferric form. The amount of iron 
normally occurring in the serum was too small to allow of 
differential analysis as to valency, but they considered that 
as added ferrous iron became oxidised, it was justifiable to 
assume that the native serum iron-protein complex was a ferrous
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compound. Barkan*s results (1933) agreed so closely with
these that he subscribed to their view. Lintgel (1931) and
Tompsett (1934 and 1940) had demonstrated that ferric iron
but not ferrous iron formed complexes with biological
materials and that such combined iron could be liberated
with pyrophosphate. Laurell, however, observed that the
claims of Starkenstein & Weden and of Barkan could not be
accepted, as the physical state of iron added in excess to
blood may be different from that of the naturally occurring
iron. His own experiments showed that only about half the
native iron could be demonstrated directly as ferric, the
remainder being demonstrable after oxidation with hydrogen
peroxide. Tompsett, he considered, had simply shown that
iron in serum could be liberated with a reducing substance,
but the amount of reducing agents (hydrosulphate and
thiolactic acid) employed had made the reaction of the
solution slightly acid, and Laurell showed that an acid
reaction in itself caused some dissociation of the serum iron
complex to occur. He also demonstrated that cautious
acidification of fresh serum in the presence of phenanthroline
to pH 5 resulted in about S0f° of the iron reacting even
without addition of any reducing substance. This could be 
interpreted as indicating that serum iron complexes were
of ferrous form. Tompsett, however, had shown that ferric
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iron was reduced to ferrous on cautious addition of acid 
in the presence of protein. There is therefore no proof 
that all of the serum iron is present in any one form, and 
experimental evidence indicates that it may occur in the 
ferrous as well as in the ferric state.
Iron normally circulating in the serum is in 
complex combination with a ^ -globulin, and the ability of 
the serum to carry iron is limited by the amount of this 
protein present, a phenomenon which will be discussed 
later. Barkan (1927) and Valquist (1941) studied the 
dialyzability of iron in this complex and found it was 
negligible at physiological pH. Valquist found that even 
when serum was enriched with iron (valency unspecified), 
the metal was still in an undialyzable form. Tompsett 
(1940) reported that excess ferrous iron dialyzed easily, 
but ferric hardly at all. All this work was done with 
physiological saline as the outer medium. In vivo, the media 
on both sides of the capillary membrane contain protein, and 
Laurell (1947) showed that this significantly altered the 
passage of iron across a membrane. Using serum as his outer 
medium, he demonstrated that when serum is enriched with iron 
under the saturation limit, all the iron is bound in an undis­
sociated and undialyzable form. Added iron in excess of the 
saturation limit is, however, loosely bound, dissociated,
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and easily dialyzable^ Excess ferrous salts dialyzed 
more readily than ferric salts. From these experiments 
it may be concluded that excess ionizable iron may leave 
the plasma by dialysis through the capillary walls. There 
is no reason to believe that it enters mature red cells 
directly. Iron enriched serum that has been incubated with 
red cells and separated again retains its total complement 
of iron as determined by chemical estimation (Cartwright 
& Wintrobe 1946 , T&tterman 1949), and radio-active iron 
added to serum in vitro does not become transferred to the 
red cells even on permitting long contact (Dubach et al.
1948). The recent work of Walsh et al#0-95O) suggests 
that direct entry into reticulocytes may occur. Even if 
this does happen the amount of plasma iron thus diverted 
must be negligible unless the reticulocyte count is high.
The site where iron is normally deposited out of the blood 
is dependent upon the form and the amount of iron which 
reaches the plasma. Studies with radioactive iron are all 
agreed that alimentary iron is largely taken up by the 
parenchymal cells of the liver and spleen, as soon as 
the immediate needs of the bone marrow have been satisfied.
In the liver, iron is chiefly periportal in distribution .
A similar distribution is found with ionizable iron given 
intravenously, and is therefore apparently due to an intrinsic 
property of portal cells to take up iron, and not to the
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manner in which the metal has entered the blood. Along 
with these parenchymal deposits, the reticulo-endothelial 
tissue of the liver and spleen and macrophages throughout the 
body also show small deposits of iron. Eventually it is 
demonstrable in other parenchymal tissues, including the 
duodenal mucosa, Brunner’s glands, outer zone of 
adrenals, proximal tubules of the kidney, and acinar tissues 
of the pancreas (^inch et al, 1950) . Poorly dissociable 
iron preparations given intravenously are taken up in 
reverse manner. They appear primarily in the reticulo­
endothelial cells of the body, and although redistribution 
into parenchymatous tissue ultimately occurs, large amounts 
remain in the reticulo-endothelial system for at least as 
long as two years if the haemoglobin has been normal at 
the time of injection (Poison, 1928; Cappell, 1930; ^inch,1950)
Iron salts which have been used for experimental 
purposes by intravenous injection include ferrous lactate, 
ferrous chloride, ferric ammonium citrate and iron ascorbate 
(Pe^). Prom the point of view of valency, it would appear 
that reduced and oxidised salts are equally suitable, as both 
forms of iron may exist naturally in plasma, and, as the 
previous discussion shows, moderate amounts given intraven­
ously are dealt with in similar manner to iron absorbed from 
the alimentary tract. The toxic effects liable to be produced
8 6
lay their administration constitute a serious drawback to 
their use and for chemical estimation to demonstrate signi­
ficant changes, it is unfortunately necessary to work with 
relatively large amounts* An intravenous dose of more 
than 6-10 mg* is usually followed by symptoms of flushing, 
upper respiratory irritation, constriction in the chest, 
nausea and vomiting, shock, central nervous system depression, 
and even coma* Milder reactions often occur even with 
considerably smaller dosage. These reactions have been 
attributed to dialysis of unbound iron salt from the 
capillaries into the tissues leading to flocculation and 
local irritation, and have proved a considerable handicap 
to investigators who have used these preparations. It 
would certainly preclude their use in any routine clinical 
test which might be established.
Radio-active isotopes have the great advantage that 
they can be given intravenously in small enough amounts to 
be comparable to the normally occurring concentrations of 
iron in the body. After administration it is, however, only 
practicable to estimate them in the red cell mass where they 
mostly appear quantitatively in the haemoglobin. This is a 
measure of utilisation and not of rate of disappearance of 
iron from the blood* Dubach et al.(1948) pointed out that
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under certain circumstances, all the iron m a y  not even 
appear in the haemoglobin* Isotopes cannot therefore be 
used as a direct means of determining the immediate rate 
of disappearance of iron from the blood stream*
There remain the colloidal preparations such as 
iron ascorbate gelatin and saccharated iron oxide. The 
latter was perfected for routine intravenous administration 
by Nissim in 1948 and trials have shown that large amounts 
can be given without serious untoward effects in the vast 
majority of cases. The proprietory preparations "Terrivenin" 
and "Iviron" can be tolerated in doses of up to 200-300 mgm. 
at a single injection. As experimental substances, they 
have the disadvantage of not being in a form comparable to 
the naturally occurring serum iron. Being colloidal 
preparations, they are primarily taken up by the reticulo­
endothelial cells and not the parenchymal cells as is the case 
with ionizable iron. Nevertheless, a small amount of the 
latter does also appear in reticulo-endothelial cells, 
immediately after administration, and the behaviour of 
colloidal iron may therefore be expected to bear some re­
lationship to the physiological metabolism of iron.
In selecting a substance for the present tests,
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colloidal iron has the great advantage that amounts suitable 
for chemical estimation can easily be administered without 
toxic effects* Saccharated iron oxide was therefore 
chosen as the test substance, and "Tviron" was used in the 
greater part of this work.
Method of investigation & variables affecting method:
The aim was to learn something of the rate of dis­
appearance of iron from the blood stream. The method 
adopted was to give a known quantity of iron intravenously 
to a fasting subject, and follow the serum iron concentration 
during the subsequent few hours.
Tests were begun between 9 and 9-30 a.m. on fasting 
subjects, and fasting continued until the test was 
completed. A dose of 5 c.c. of saccharated iron oxide 
(100 mg. elemental iron) was given intravenously over a 
period of 5 minutes. Blood for serum iron estimation 
was taken from the same arm immediately before iron admin­
istration, and from the opposite arm at 5 min., 0.5 hr.,
1.5 hr., 4.5 hr. and 7*5 hr. after the iron had been given.
On performing such a test on 13 normal people be­
tween the ages of 18 and 62 years, the 5 minute level was 
found to be unexpectedly low, and was not significantly 
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injection (Table 16)* Pactors which, require special 
consideration as possibly affecting this result are the 
accuracy of recovery of iron from "Iviron", and the 
properties of colloidal iron in relation to plasma iron- 
combining capacity, adsorption, dialysis and excretion. 
Recovery of iron from "Iviron";
In previous work serum iron estimations have been 
performed following intravenous loading with simple iron 
salts. These are recovered quantitatively from serum, 
as has been confirmed in the present work, and it is 
consequently justifiable to conclude that any iron not 
estimated in a serum sample taken after giving such a 
preparation intravenously must have been eliminated from 
the blood stream. Saccharated iron oxide is colloidal, 
and it was therefore indicated to assess the efficacy with 
which its iron content could be recovered from serum using 
the methods chosen for serum iron estimation*
Dilutions were made of '‘Iviron" in water and of 
"Iviron" in serum, so that 100 ml. of the mixture contained 
known amounts of iron. The amount recovered is shown in 
Table 17. Recovery of the total iron is obviously 
inadequate but is apparently directly proportional to the
91
Table 17. Recovery of iron after addition of a known 
quantity of "Iviron” to water or serum.




•Iviron" in water 500 140 2b. 0
H H it 500 160 32.0
it ti H 1000 365 36.5
•Iviron" in serum 500 155 31.0
ti it it 500 172 34.4
M ti ii 1000 300 30.0
ii H ii 1500 480 3 2 . 0
Table 18♦ Recovery of iron from iron-enriched serum 
before and after its incubation for 1 hour with washed 
red cells, iron being added as "Iviron" and estimated 
by the ashing technique.
Sample
No.
Iron content of 
serum used,
Ug. fo
Iron content of 
serum + "Iviron"
Ug. 7b
Iron content of 




1 950 4400 3500
2 700 3450 4500
3 250 3005 3505
4 105 3300 3000
5 210 3760 4250
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strength of the iron dilution being estimated, an average 
of 32$ being accounted for in each specimen* By ashing, 
the iron content of ^Iviron” was found to be accurate to 
within 3$. This constant experimental error explains only 
partially the relatively low concentration of serum iron 
5 minutes after a large injection*
Iron binding capacity of serum in relation to "Iviron*1
Waldenstrom (194-4) observed that five minutes after 
intravenous injection of 10 mg* of iron as a simple salt, 
the serum iron value was lower than was to be expected 
if all the iron had been distributed in the plasma 
volume of the organism* Repeat injections at a short 
interval resulted in only small rises, and toxic symptoms 
of flushing, nausea, sneezing and headache appeared*
He was therefore able to postulate that there was something 
which controlled the maximum serum iron level attainable 
at an average of 291 ug*$ in normal subjects, and that 
iron in excess of this was rapidly eliminated from the 
blood causing toxic symptoms* Holmberg (1941) had 
previously advanced the hypothesis that iron was bound to 
the serum proteins in complex manner up to a certain sat­
uration limit, and any excess was loosely bound and easily 
split, a hypothesis which was later proved tenable by in
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vivo experiments. The saturation limit in his findings 
had an average value of 312 ug.$ in normal people 
(Holmberg & Laurell, 1947)* The experiments of Schade & 
Caroline (1946) established that the iron-binding com­
ponent is Cohn's Fraction IV-3.4 which is rich in 
/3 -globulins. They determined the iron-binding capacity 
at an average of 260 ug.$ in health. Normally, this iron- 
binding component is saturated to approximately one-third of 
its capacity. Cartwright & Wintrobe (1949) found that the 
capacity of this protein to bind iron was so specific that 
estimation of the iron-binding capacity of the serum could 
probably be made by estimation of the serum iron concentrat­
ion after injection of an excess of iron intravenously.
Again, these findings are based on experiments made with 
simple iron salts. In this work, even making allowance for 
the experimental error in estimation of iron in "Iviron" 
a proportion of the saccharated iron oxide is unaccounted for 
at a very short interval after its injection (Table 16).
It seems justifiable to attribute this deficit to the 
influence of the serum iron binding protein. Such iron as 
is "bound" presumably remains for a longer time in the cir­
culation while the excess is almost immediately eliminated.
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Adsorption and dialyzing properties of "Iviron" and excretion;
In accounting for this initial rapid disappearance of 
"Iviron’1 from the circulation it is necessary to consider the 
possibility of adsorption on the cellular elements of the 
blood, of penetration through the capillary vessel walls, of 
excretion from the body.
Adsorption and dialysis:
The equivalent of 3 mg. elemental iron per 100 ml. serum 
was added as "Iviron" to serum, and 10 ml. of the mixture 
allowed to stand for 1 hour at 37°C. in contact with 10 ml. of 
packed red cells which had been washed in normal saline. The 
serum was then Separated again and its iron content estimated. 
The ashing technique was used (Table 18). The variation in 
results can be attributed to inaccuracy encountered with the 
less delicate ashing method of estimating iron concentration 
and to slight haemolysis which is liable to occur in using 
packed red cells and subsequently re-separating them. It is, 
however, evident that significant adsorption of iron does not 
occur. As far as is known there is no question of this 
colloidal preparation dialysing through the capillary walls. 
Excretion:
The question of iron excretion in health and after 
oral iron ingestion, haemolysis and blood transfusion has 
already been discussed and published work indicates that it 
is minimal. The excretion of iron after intravenous
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administration of saccharated iron oxide is greater but is 
still relatively slight. Scott & G-ovan (1951) in a 
limited investigation found that 5$ might appear in the urine 
after giving moderate amounts. Crawley (personal 
communication,1951) demonstrated negligible excretion from 
the bowel and limited excretion from the Sidneys. The 
latter ranged from 2.9 “ 4*4$ of the dose given and was 
unrelated to the haemoglobin level at the time of administr­
ation. Although the most of this amount was excreted in 
the first 24 hours the total was that for a 3 day period. 
Excretion during the time of an intravenous iron disappear­
ance test must therefore be negligible and certainly cannot 
account for the speed at which the iron leaves the blood 
stream.
Neither adsorption, dialysis nor excretion can be 
held responsible for the rajid disai^pearance of injected 
1 Iviron”. The evidence suggests that the serum is capable
of holding the preparation only up to a certain maximum 
level, probably dependant upon the iron-binding capacity, and 
that the excess disappears extraordinarily rapidly from the 
circulation but is nevertheless retained within the body. 
Since it is unaccounted for by dialysis or adsorption it may 
all be transferred to the reticulo-endothelial system.
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Interpretation of intravenous iron disappearance tests:
The curves obtained by the test described have two 
phases. There is an initial rapid disappearance of injected 
iron to a level probably dependant upon the iron combining 
capacity of the serum, and a secondary slower disappearance 
of iron which has presumably been protein-bound. The rate 
of this secondary disappearance in different subjects can 
best be compared by expressing serial estimations as per­
centages of the 5 minute concentration. In thel3 normal 
people this disapx^earance rate is very similar (fig.21).
Since the iron does not appear to leave the plasma 
excretion, dialysis or adsorption, its rate of disappearance 
below the saturation limit can be expected to be affected by 
the body's requirement for iron. The curves may therefore 
be used for comparison of the iron-binding capacity of the 
serum as represented by the levels 5 minutes after injection 
of excess saccharated iron, and to indicate the rate at which 
iron subsequently disappears from the plasma.
Application of method to patients with Anaemia;
from the immediately preceding discussion it is evident 
that an intravenous iron disappearance test using "Iviron" is 
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gig. 21. Disappearance rate of '’Iviron" injected 
intravenously in normal subjects.
Table 19* Material on which intravenous iron disappear 
ance tests were performed.
Nature of illness. No. of cases.
Chronic hypochromic anaemia 15
Anaemia from recent massive 
haemorrhage. 7
Befractory normoblastic anaemia
- in toxic states 5
- in infections 13
- in neoplastic disorders 15
Pernicious anaemia 9
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(Fig.21), are comparable, and when repeated in three of the 
group, the form remained similar. There is therefore a 
characteristic pattern for intravenous iron disappearance 
curves in healthy x^ eople which is suitable as a standard 
of comparison for curves obtained in disease. Application 
of the test was consequently extended to patients suffering 
from various forms of anaemia.
Material: The accompanying table indicates the cases in­
vestigated by means of intravenous iron disappearance tests 
(Table 19)* All patients with chronic hypochromic anaemia 
had a haemoglobin deficiency (as indicated by a colour 
index of less than 0.9) and active normoblastic erythro- 
poiesis. The patients with toxic, infective or neoplastic 
diseases had colour indices between 0*9 and 1.1, except two, 
who had hypochromic anaemia. The marrow reaction in this 
group was active and normoblastic. The cases of pernicious 
anaemia were of classic type, with raised colour index, 
megaloblastic marrow and histamine-fast achlorhydria.
Results;
Figures and curves obtained are shown in Table 20 and 
Figs. 22 to 27. As previously explained the curves are 
obtained by expressing the serial readings as percentages of
100
Table 20. Serum iron concentration after injection of 100 





Hb. R.B.C. mill. 
/ c.mm
C.I. Serum iron, ug.y
Initial 5 min. after 
ICO mg."Iviron
Chronic 1 60 4.3 0.7 35 452
hypo­ 2 42 3.6 0 . 6 58 590
chromic 3 51 3-9 0.7 40 600
- post 4 46 3.4 0.7 48 651
haemorr- 5 70 4.5 0.3 42 700
hagic 6 45 3.9 0. b 33 623
7 57 4.2 0.7 20 562
8 39 3.3 0.5 15 452
9 63 4.5 0.7 47 682
10 55 3.8 0.7 39 640
idio­
pathic 11 64 4.0 0 . 8 15 600
12 59 4.2 0.7 31 502
13 46 3.0 0.7 30 573
14 40 4.1 0.5 46 570
15 46 5.0 0.5 35 550
Recent 1 70 3.6 1 . 0 106 500
massive 2 63 3.4 i.i 120 530
haemorr­ 3 72 3.8 1 . 0 189 421
hage 4 58 3.3 0 . 9 100 412
5 60 3.1 1 . 0 98 488
6 75 4.0 0 . 9 133 545
7 63 3.5 0 . 9 90 440
Pernic­ 1 50 2.2 1.12 150 506
ious 2 40 1.4 1.40 130 493
anaemia 3 61 2.5 1.22 126 450
4 38 1.5 1. 2b 143 430
5 72 3*2 1.12 118 350
6 52 2.0 1.30 102 412
7 63 2 . ( 1.16 63 500










C.I. Serum iron, ug.^
Initia-L 5 min after 
100 mg. "Iv­
iron"
Toxic 1 41 2.4 0.9 38 400
2 73 3-5 1.0 59 427
3 60 3-4 0.9 78 400
4 68 3*2 1.0 60 437
5 50 2.6 1.0 70 905
Infect­ 1 69 3.4 1.0 135 390
ive 2 63 3.4 0.9 50 4Cj>
i 74 3*6 1.0 45 400
4 76 3.2 0.9 45 430
5 60 3.0 1.0 58 372
6 60 3 • 5 0.9 48 330
7 54 2.8 1.0 62 403
8 73 3.6 1.0 55 450
9 70 3*3 0.9 74 370
10 63 3*6 0.9 55 390
11 78 4*1 0.9 72 480
12 68 3.4 1.0 61 461
13 57 3.1 0.9 75 351
Neo­ 1 64 4.4 0.8 40 400
plastic 2 70 3-5 1.0 38 d ' 6 1 .
3 74 3.8 1.0 54 340
4 50 2.8 0.9 63 300
5 75 3-b 1.0 42 370
6 54 3.7 0.8 6± 432
7 52 2.6 1.0 60 330
8 6i 2.9 1.0 113 452
9 52 2.9 0.9 81 350
10 5b 3.0 1.0 7-l 422













14 67 3*8 0.9 50 411
15 59 2.7 0.9 44 379 
.. .. -1
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Fig. 22. Chronic hypochromic anaemia - rate of 
disappearance of iron after intravenous injection 





Fig. 23. Recent massive haemorrhage - rate of
disappearance of iron after intravenous injection
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Fig. 84 Anaemia of toxic states - Rate of dis­













Fig. 25. Anaemia of infection - rate of disappear­
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Fig. 26. Anaemia of neoplastic disease - rate of 
disappearance of iron after intravenous injection 
of 100 mg. "Iviron".
IOO
normal range
2 3 4  5 6 7
TIME IN HOURS
Fig. 27* Pernicious anaemia - rate of disappear­
ance of iron after intravenous injection of 100 mg.
"Iviron".
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the 5 min. level (the maximum level produced) in order to 
demonstrate the rate of disappearance.
The two phases of the curves obtained will be con­
sidered separately:
(a) Level produced after infection of iron considered in re­
lation to plasma iron-binding capacity;
(b) Subsequent rate of fall in relation to body require­
ments for iron.
Results in relation to iron binding capacity:
The various groups showed characteristic levels in the 
concentration of serum iron recorded 5 minutes after the 
injection of “Iviron*' (Table 21). If the findings of 
Cartwright & 7/introbe (1948) are applicable to colloidal 
iron, these figures can be regarded as representative of 
the iron-binding capacity of the serum. They would indicate 
that when compared with normal this is raised in chronic 
iron deficiency both of idiopathic and post-haemorrhagic 
type, and lowered in the refractory toxic, infective and 
neoplastic anaemias and in pernicious anaemia. Shortly 
after massive haemorrhage there is no significant change. 
Comparison with the findings of Laurell (1947) in similar 
diseases after direct estimation of the iron—binding cap­
acity of the serum shows close similarity in the manner in
Table 21. Average serum iron levels after injection 
of loO mg. of "Iviron" intravenously.
Type of 
cases
Av. serum iron level 
5 min. after 100 mg. 
"Iviron", ng.fo
Av. initial serum 
iron level, ug.^ _ 
















which the level varies in the different groups of diseases, 
thus supporting the view that the level attained after 
injection of "Iviron'* is under the control of the serum 
iron-binding capacity, Laurell draws attention to the 
fact that the serum iron-binding capacity does not vary 
in proportion to the resting serum iron concentration, and 
from his findings concludes that when iron is being stored 
in the organs, as after haemolysis,the quotient of the 
manifest iron-binding capacity (indicated by resting serum 
iron concentration) to the latent iron-binding capacity 
(the portion of the iron-binding protein which is not 
saturated) is higher than normal, whereas when iron is 
having to be mobilized from the depots, this quotient is 
greatly increased. Such a conception is supported by the 
present figures.
Hate of disappearance:
In previous work published, the rate of fall of the 
serum iron after the maximum level has been reached has 
received comparatively little attention, Hrom the present 
findings, it appears that in chronic hypochromic anaemia 
there is an increased rapidity in the rate of disappearance 
of the protein-bound iron. In refractory normochromic 
anaemia associated with toxic, infective and neoplastic
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disease, there is also a tendency to an increased rate of 
disappearance, in spite of the fact that there is no 
evidence of hypochromia and the anaemia is refractory to 
iron. In pernicious anaemia there is delay in disappear­
ance, In chronic iron deficiency, an increased demand for
iron by the body is undoubted, and provides a rational 
explanation for the rapid disappearance of iron from the 
blood. In pernicious anaemia there is maturation arrest 
of the marrow presumably resulting in much smaller iron 
Requirements. Platter disappearance curves are therefore 
not surprising. If the findings in these two groups can 
be regarded as indicating that demand for iron determines 
the rate of its disappearance from the blood, then in the 
refractory toxic, infective and neoplastic anaemias, there 
may be a need on the part of the tissues for iron for some 
purpose other than haemoglobin formation. Cartwright et al. 
(1946) and Totterman (1949) have already demonstrated an 
increased rate of intravenous iron disappearance in infect­
ive diseases. It is of interest that the toxic and 
neoplastic groups here show similar patterns, as Heilmeyer 
(1 9 3 7) assumed that an important aetiological factor in 
all these anaemias was deviation of iron from the bone
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marrow* Deviation in infection has not been accounted for by 
abnormal excretion of iron in the urine or bile, even when 
iron is given intravenously (Hahn et al. 1939) and Schafer's iron 
balance studies on children with sepsis (1940) also showed no 
increase in iron excretion. The findings presented later are 
contrary to Heilmeyer's idea that there is in fact deviation 
of iron from the marrow. The marrow certainly seems incapable 
of using iron normally in these refractory states but it 
appears that this may actually result in accumulation of iron 
there.
The rate of disappearance of iron from the plasma is 
not related in these experiments to the serum iron binding 
capacity. The serum iron binding capacity is high in iron 
deficiency anaemias and low in chronic refractory anaemias, 
yet the rate of iron disappearance from the blood is rapid in 
each. Cartwright and Wintrobe (1949) restored the serum 
iron-binding capacity to normal in two patients with infection 
by intravenous injection of metal-combining globulin but were 
unable in this way to affect the rate of disappearance of 
subsequently injected iron.
SUMMARY;
The suitability of saccharated iron oxide as a
110
test substance for studying the rate of disappearance of 
iron from the blood has been discussed and the possibility of 
dialysis, adsorption and excretion considered. In spite of 
considerable experimental error in recovery of the iron content 
of such a preparation by the techniques chosen, the substance 
has been found useful for demonstrating relative differences 
in serum iron-binding capacity in different groups of anaemia 
and for performing intravenous iron disappearance tests.
SimpLe iron deficiency anaemia appears to be associated 
with an increase in plasma iron-combining capacity, while 
refractory normoblastic anaemia and pernicious anaemia are 
associated with a reduction. This reduction is greatest in 
pernicious anaemia. A differential rate of disappearance of 
iron from the plasma is demonstrable but is unrelated to the 
iron-combining capacity. The fact that the rate of disappearance 
is increased in chronic iron deficiency and decreased in pernicious 
anaemia suggests that it may be affected by iron requirement.
An increased rate of disappearance is evident in the refractory 
anaemias associated with chronic toxic, infective, and neoplastic 
diseases. This selective rate of disappearance must be the 
result of differences in internal iron metabolism since all 
available evidence is in agreement that excretion, even of 
intravenously administered iron,is minimal.
The findings obtained by intravenous disappearance 




ORAL IRON ABSORPTION TESTS.
Prora a series of experiments performed by McCance 
and Widdowson, (1938) and Whipple, (1939), it can be con­
cluded that the organism maintains its iron balance prin­
cipally through control of absorption, and that iron ex­
cretion is a function of secondary interest lacking major 
physiological significance. The investigations of Mitchell 
and Hamilton (1949) suggested that significant amounts of 
iron are excreted in the sweat. Their findings, however, 
are difficult to accept, as they claim an excretion of 
6.5 gms. of iron daily in this manner, an amount which ex­
ceeds the average daily intake. This relatively one-sided 
control of the body*s iron content makes possible the study 
of iron absorption by oral iron loading tests. Shortly 
after the establishment of various methods for estimating 
serum iron, numerous workers found that the serum iron 
level rose after oral ingestion of iron, Moore et al , 
(1939) recognised that this offered for the first time a 
means of making a direct comparison of the degree of iron 
absorption under different local conditions in the aliment­
ary tract. Previous workers in investigating the amount of 
iron absorption had had to rely on such indirect methods as
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measurement of the deficit in alimentary excretion of iron 
after ingestion of a known quantity (Fowler and Barer,
1935; Widdowson and McCance, 1937); estimation of the amount 
of iron removed from isolated segments of intestine under 
experimental conditions (Abbott and Miller, 1936); or 
determination of the total increase in circulating haemo­
globin resulting from medication with a given amount of iron 
(Whipple and Robbins, 1936; Heath, 1933; Hahn, 1937). The 
iron balance type of investigation offered great technical 
difficulties in that the amount of iron absorbed was so small 
compared with the amount ingested and excreted. In the 
isolated intestinal loop there was the possibility that ab­
sorption on the mucosa accounted for the disappearance of 
some iron presumed at the time to have been absorbed. 
Measurement of the haemoglobin increase incurred assumption 
that all absorbed iron was utilised for haemoglobin forma­
tion and none was diverted elsewhere. Moore and his assoc­
iates were limited in the interpretation of their oral ab­
sorption curves by lack of knowledge regarding the rate of 
Iron disappearance from the plasma. They were, however, able 
to show that soluble iron salts are absorbed exclusively into 
the blood stream, and not at all into the lymph, and, contrary 
to the experience of several other workers, that closely 
parallel curves could be obtained in the same subjects under
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standard conditions. Insoluble iron salts, they found, 
were not absorbed at all, while ferrous preparations were 
somewhat better absorbed than ferric. Reducing substances 
aided absorption of the latter, but also often Increased 
the uptake of ferrous iron. With the information available 
from the present work regarding the rate of disappearance 
of iron from the blood stream, it was decided to explore 
further the value of oral absorption tests in the investi­
gation of various forms of anaemia.
Method: In selecting a substance for performance 
of oral Iron absorption tests, the aim was to use a pre­
paration which was readily procurable, reasonably palatable, 
and in liquid form. The amount of iron given was, of 
necessity, going to be far in excess of the average physio­
logical iron intake, but it was none the less desirable to 
use the smallest quantity with which consistent results 
could be obtained. A dose of 45 gr. ferric ammonium citrate 
was found to fulfil these requirements. This dose was given 
in the morning to fasting subjects, and samples of blood 
were taken for serum iron estimation immediately before 
giving the iron and at 2, 4, end 7 hours afterwards. In a 
few instances, samples were taken at 1 and 3 hours afterwards 
as well, but as the maximum level was found to occur almost 
invariably in the 2-hour specimen, the intermediary estiraa-
Table 22. Cases investigated by oral iron absorption 
tests.








- in toxic states 8
- in infections 16
- in neoplastic diseases 12
1 16
tions were discontinued. Intolerance to this dose of iron 
was minimal and only once resulted in vomiting.
In order to compare the degree of iron absorption in 
individual cases, the resting serum iron concentration was 
subtracted from subsequent values. The curves therefore re­
present the actual increase produced by oral iron loading. 
Changes in plasma volume in anaemia must influence the con­
centration of iron recorded, but as the difference in various 
forms of anaemia appeared significant without making such 
allowance, plasma volumes were not calculated.
Material: The accompanying table, (Table 22), indi­
cates the material investigated by oral iron absorption tests.
Curves obtained in normal subjects: The results ob­
tained in 10 normal subjects are shown in Fig.28a. The group 
included both sexes, and the ages ranged from 18 to 65 years. 
All persons had a normal blood level and normal blood sedi­
mentation rate, and physical examination of each was entirely 
negative. The maximum increase in serum iron concentration 
produced is seen to range from 18 to 83 u;g. per cent. Indi­
vidual curves were reproducible (Fig.28b), indicating that 
this variation must be due to intrinsic characteristics in 
the subjects, and not to inaccuracies arising from the method. 
The criticism may be raised that the smaller changes produced 
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gig. 28a. Oral iron absorption curves in normal
subjects.




gig. 28b. Repeat oral iron absorption curves in
normal subjects.
1 1 8
Nevertheless, since the changes were consistently positive 
and occurred shortly after iron administration, it seems 
reasonable to assume that they represent alimentary iron 
absorption.
The fasting serum iron concentrations are indicated 
as figures on their respective curves. Superficial examina­
tion suggests that the height of the curve after loading 
bears an inverse relationship to the fasting concentration. 
The numbers are too few for this to be anything further than 
an observation, but this tendency was observed by Thedering 
(1948). From analysis of 314 curves of his own and 27 
collected from the literature, he showed that this relation­
ship was statistically significant and used it to support 
his view that control of serum iron, like that of other 
physico-chemical systems in the body, is under autonomic 
influence. According to Wilderfs Law, (Wilder, 1951), the 
fasting levels, ('Starting values11)^ are dependent upon the 
state of equilibrium in the autonomic nervous system, and 
when autonomic stimulation happens to be present at the 
moment of the experimental observation being made, weak or 
even paradoxical responses may be expected. The level of 
the resting serum iron concentration, he concluded, affects 
the type of absorption curve obtained. On the other hand, 
using a radioactive technique,lubach et al.(1948) produced results 
indicating that the serum iron level did not affect
119
absorption directly. Iron introduced intravenously to 
raise the serum concentration to 500 ug.$ did not alter the 
amount of an oral dose absorbed.
Analysis of oral iron curves in chronic hypochromic anaemia.
Twentytwo cases of chronic hypochromic anaemia were 
investigated. These are divided into two sub-groups accord­
ing to whether or not haemorrhage could be demonstrated.
In neither group could dietary deficiency or multiple preg­
nancy be considered as contributing to the anaemia. Twelve 
cases were regarded as examples of essential idiopathic hypo­
chromic anaemia, and in these, thorough investigation, in­
cluding X-ray of the alimentary tract and examination for 
occult blood in the stools, revealed no evidence of abnormal 
blood loss. In the other 10 cases, haemorrhage could defi­
nitely be regarded as an important causal factor in the 
anaemia. In these patients bleeding was manifested as menorr­
hagia, chronic haemorrhage from piles, or chronic bleeding 
from peptic ulcer. Patients in whom there was doubt regard­
ing the possible role of blood loss in precipitating their 
anaemia were not included in the investigation. The curves 
obtained are shown in Figs.29. and 30. A striking feature 
in both groups is the wide variation in the serum iron 
levels recorded at 2 to 4 hours after iron administration.
This spread is not wholly a chance occurrence, because re­
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Fig. 29. Oral iron absorption curves in post* 
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Pig. 30. Oral iron absorption curves in idiopathic 
iron deficiency anaemia.
12 I
results, thus Indicating that the amount of iron 
absorbed is characteristic for each individual. The 
curves were therefore investigated in relation to the 
following factors which might possibly influence iron 
absorptions (1) Age and sex; (2) Gastric acidity.
(3) Haemoglobin level - this represents to some extent 
the body iron reserve at the time as the haemoglobin 
level probably does not fall till available tissue iron 
is exhausted, (Vannottii and Delachaux, 1949). (4) Bodyfs 
ability to utilise iron given as indicated by the rate of 
haemoglobin regeneration. (5) Simultaneous rate of dis­
appearance of iron from the serum.
Age and sex as influencing iron absorption in hypochromic 
anaemia; Only 3 of the 24 cases were males so that sex is 
not a factor concerned. There is also no close relationship 
to age. One of the flat curves and one of the steep curves 
are both from patients aged 21 years. The ages of the re­
mainder of the group likewise show no relation to the 
curves obtained, but the ages range only up to 48 years, 
which is perhaps too limited on which to make any signifi­
cant comparison.
Effect of gastric acidity on iron absorption in hypochromic 
anaemia: In all cases the fasting stomach contents were
tested for the presence of free hydrochloric acid. Histamine
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(0.5 ml.) was given if there was no free acid present, 
and the juice tested again 15 mins., and if necessary, 45 
mins., later. Cases with histamine-fast achlorhydria are 
indicated in the charts and it is apparent that there is 
no relationship between the height of the s erum iron curve 
and the occurrence of achlorhydria. This raises the problem 
regarding the role of hydrochloric acid in iron absorption 
and therefore in the production of snaemia. There is eviden­
ce that normal gastric acidity is probably required for 
optimal assimilation of food iron (Barer and Fowler, 1937; 
Kellogg and Mettier, 1936; fltyemsB j" ), but there is
doubt regarding the effect of gastric acidity on the absorp­
tion of metallic iron salts in therapeutic doses. Brock 
and Taylor (1934) showed that dialysis of soluble inorganic 
iron salts is hastened by the addition of small amounts of 
mineral acid and retarded if the solution is made alkaline. 
Halvorsen and Starkey (1927) had previously shown that at a 
pH of over 5.0, only small concentrations of iron are present 
in solution. In therapeutic trials Mettier and Minot (1931) 
obtained a higher reticulocyte response when they gave iron 
and ammonium citrate in an acid-buffered medium than when 
they gave it in an alkali-buffered medium, a finding confirmed 
again in later work (Minot and Heath, 1932). On the other 
hand, B&rer and Fowler (1937) obtained as much retention of
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iron after high dosage in subjects with an achlorhydria 
as in those with normal gastric acidity, and Moore et al. 
(1939), although observing lower absorption levels of 
ferric salts than ferrous salts given in massive dosage, 
found no significant relationship to the presence or absence 
of free hydrochloric acid in the gastric juice. Workers 
using reduced iron as their test agent, (Heilmeyer and 
Pltttner, 1937), did find that hydrochloric acid aided ab­
sorption as it increased solution and ionization of the iron 
in the gastro-intestinal tract. When soluble ionized salts 
are given, hydrochloric acid may assist in preventing their 
change into insoluble and undissociated compounds (Tompsett, 
1934 and 1935).
My own investigations show not only that iron may be 
very well absorbed in the presence of achlorhydria, but also 
that it may be relatively poorly absorbed when gastric acid­
ity is normal. In 3 cases showing poor absorption and 
achlorhydria, a similar dose of iron was given along with 
20 minims dilute hydrochloric acid. No alteration in the 
absorption curve resulted (Pig. 30a). In interpreting these 
results, it must be remembered that the iron preparation used 
was in itself acid and was given in massive dosage. Its own 
acidity might counteract any necessity £or the presence of 
hydrochloric acid to maintain a suitable medium for absorp­
tion, and the high dosage might overcome any mucosal barrier.
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Fig. 3Ca. The effect of 20 minims dilute hydrochloric 
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Fig. jl. Maximum absorption levels in relation to 
haemoglobin levels in iron deficiency anaemia.
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The technique is therefore probably not suitable for 
analysing the role of hydrochloric acid in the absorption 
of iron under physiological circumstances. It does however 
indicate that when iron is given in therapeutic dosage, 
the addition of hydrochloric acid is of no further benefit. 
Absorption of iron in relation to haemoglobin level and 
utilisation: When absorption levels are related to haemo­
globin levels, no correlation is seen (Fig.31). This is 
perhaps to be expected. The circulating haemoglobin iron 
is intracellular, and therefore unlikely to influence in­
testinal absorption of iron directly. An idea of effic­
iency of utilisation of iron can be obtained only from 
comparing the relative rates of haemoglobin regeneration. 
This is obviously unsatisfactory, as any such comparison 
must presuppose a uniform rate of utilisation of absorbed 
iron. In the present work it is also unfortunately not 
possible, as patients received varied forms of treatment 
after the initial investigations were performed. The use 
of radioactive iron would provide the most satisfactory 
answer. Dubach et al.(1946) showed that radioactive iron 
given intravenously appeared more rapidly in the peripheral 
blood in patients with chronic haemoglobin deficiency due to 
blood loss than in normal subjects. They make no comparison 
of rates of utilisation in different patients with iron 
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Oral absorption curves in relation to the rate of disappear­
ance of iron from the serum; Local conditions in the 
alimentary tract may impede iron absorption, and result in 
flat curves after oral iron loading, but such curves could 
also be due to unusually rapid disappearance of iron from 
the serum. It has already been shown that the rate of dis­
appearance of intravenously injected iron is raised in iron 
deficiency anaemia as a group (Fig.22). To compare individual 
results both oral and intravenous iron tests were performed 
on three patients before treatment (Fig.32). On these 
results the relative rate of iron disappearance from the 
serum does not account for the differences in oral curves. 
Comparison of oral curves in essential and post-haemorrhaglc 
chronic iron deficiency: From these investigations no
obvious feature emerges to account for the variable curves 
obtained. Age, sex, gastric acidity and rate of disappear­
ance of iron from the serum have no significant demonstrable 
influence. If the cases are considered in their two groups, 
however, one observation seems justified. In the idiopathic 
group, 6 out of 12 curves show a rise of less than 100 ug.$. 
at any point in their course, while in the post-haemorrhagic 
group, all of 10 curves rise more than 100 u:g.$. The possi­
bility of differences in alimentary absorption should be 
considered further. The flatter curves in idiopathic
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hypochromic anaemia might indicate an impaired ability 
to absorb iron. The fact that there is no clear-cut 
difference in the curves of the two groups is not necess­
arily disconcerting. The idiopathic group is almost 
certainly a heterogeneous one, since cases are classed as 
such simply because no cause has been found for the anaemia 
at the time of examination, and the post-haemorrhagic 
group could quite well include cases in whom defective 
absorption of iron had hastened the development of anaemia. 
Presumably if these groups show differences in their 
ability to absorb medicinal iron when the need is similar, 
there may also be differences in their ability to absorb 
food iron under normal circumstances. If such a primary 
defect in iron absorption is postulated, it means adding 
yet another factor to the already long list of possible 
aetiological factors in iron deficiency. The cases classed 
here as essential idiopathic hypochromic anaemia do, however, 
seem to indicate that such an abnormality is deserving of 
consideration. All were apparently taking a balanced and 
adequate diet, none showed anything to suggest an increased 
demand for iron, none had any signs of abnormal blood loss, 
(several of the females had even passed the menopause), and 
many had normal gastric acidity.
The conception of a possible primary defect in the
mechanism of iron absorption in essential hypochromic 
anaemia is not a new one. Lederer (1939 and 1940) performed 
a series of experiments from which he concluded that libera­
tion of complex food iron in normal subjects is effected by 
means of an enzyme acting in the presence of free hydro­
chloric acid. His findings demonstrated that in idiopathic 
hypochromic anaemia this enzyme is absent, while in pernicious 
anaemia it is present but inactive, owing to achlorhydria.
In this way he accounted for otherwise unexplained cases of 
hypochromic anaemia. I have been unable to find any work 
either confirming or disproving Ledererfs theory. If such 
an enzyme does, in fact, exist, but requires hydrochloric 
acid in order to function, it is difficult to understand why 
there is not a much greater incidence of iron deficiency 
accompanying pernicious anaemia. Thedering (1949) found 
poorer alimentary absorption of iron during recovery in 
"idiopathic1 iron deficiency patients than in patients with 
chronic post-haemorrhagic anaemia, and concluded that mal­
absorption of iron was a basic factor in the production of 
unexplained iron deficiency anaemia.
Surprisingly little attention has in fact been paid to 
the subject of iron absorption in the fasting individual. 
Dietary factors under such conditions are eliminated, and 
the iron uptake can be assumed to depend purely upon demand 
by the drganism for iron and upon local conditions in the
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alimentary tract* There is no doubt from published work 
8nd from the present curves that great need for iron, such 
as occurs in post-haemorrhagic anaemia, leads to a great 
increase in the amount of iron absorbed (Hahn et al# 1939-a; 
Custom & Greenberg, 1940; Balfour, 1942). In regard to 
local conditions, hydrochloric acid has already been discussed 
and regarded as of little significance in connection with 
absorption of iron in therapeutic doses, but possibly of 
significance In maintaining a suitable medium for liberation 
of iron from food complexes. Apart from this, the only 
studies on local conditions appear to have been by Taylor 
et al. (1931 and 1935), and Gillman and Giliman. (1945).
Taylor and his colleagues observed that ligature of the 
pancreatic duct or removal of the pancreas resulted in ex­
cessive accumulation of iron in the body, particularly in 
the peripheral parenchymal cells of the liver lobules.
They claimed that this was accompanied by atrophic changes in 
the epithelial cells lining the gut. These findings were con­
firmed by Gillman and Gillman, (1945). There is evidence, 
therefore, that change in composition of the upper alimentary 
tract secretions other than alteration in acidity may affect 
the assimilation of iron. The present findings suggest that 
such may play a part In production of idiopathic iron defic­
iency anaemia. If such a defect does exist, it must be
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readily overcome in the majority of cases by massive oral 
iron intake, as is evident from the fact that all patients 
responded satisfactorily to routine oral iron medication.
No examples of simple iron deficiency fefractory to oral 
iron were encountered during the treatment of 189 cases of 
uncomplicated chronic hypochromic anaemia, only five of which 
required admission to hospital for adequate supervision of 
treatment. The opportunity was not therefore obtained for 
performing absorption tests in a selected group in which
I
malabsorption could be suspected.
Oral absorption curves in gastro-enterostomy: Accumulated
data on the problem of anaemia in patients who have under­
gone gastric operations indicate that there is a definitely 
higher incidence of anaemia in this group than in the general 
population. Whitby and Britton (1950) state that ”there can 
be little doubt that anaemia after gastric operation is the 
result of the surgery”. In the vast majority of cases it is 
hypochromic in type (Taylor et al, 1929; Morley & Roberts,1928 
Hartfall, 1934; Lublin, 1931,), hut Vaughan (1932) showed tnax[ 
there may in fact be a dyshaemopoietic element in addition to j 
the iron deficiency in a considerable proportion of cases.
Two satiological factors are commonly suggested. Firstly, 
regurgitation of alkaline intestinal juices may make the 
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rig. 34. Intravenous iron disappearance in rel- 
ation to oral iron absorption in gastro-enterostomy.
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of iron from the food. Secondly, unduly rapid transit of 
food through the upper alimentary tract may not allow time 
for the iron to he separated and assimilated, Lublin 
(1931) studied the acidity of the stomach after gastro­
enterostomy, and found normal or hyperacidity present.
It therefore appears that local changes in acidity can 
have little significant role in production of the anaemia. 
Mechanical changes resulting from such operation may well 
be such as to predispose to anaemia from malabsorption 
due to intestinal hurry. Such malabsorption might be 
revealed by oral iron absorption curves.
Oral iron absorption tests were performed in 12 
consecutive cases of gastro-enterostomy presenting on account 
of symptoms of anaemia. Six of these were males. Operation 
had been performed one to thirty years previously because of 
peptic ulcer. The anaemia was of moderately severe hypo­
chromic type in all instances, and the bone marrow, examined 
in each, was active and normoblastic. In 9 cases the iron 
absorption curves were high, and in 3 they were normal (Pig.33) 
In two of the patients with low curves and in two with high 
curves intravenous iron disappearance tests were performed 
(Pig.3.4). A consistent relationship between alimentary 
absorption of iron and rate of disappearance from the serum
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was not established, and it would appear that differences 
in absorption curve levels have to be attributed to 
differences in the amount of iron absorbed from the 
alimentary tract. The proportion of cases showing low 
curves (3 out of 12) is surprisingly small if malabsorption 
is the main aetiological factor in producing the anaemia. 
Nevertheless, two of the patients with low curves had been 
taking supplementary iron orally in considerable amounts 
for several months without effect. Another patient on whom 
an absorption test was not performed had been treated on two 
previous occasions for hypochromic anaemia. During the 
eighteen months prior to being seen she had taken Colliron and 
Vitamin C. daily, but the haemoglobin remained around 40$ 
and the red cell count at just over 4 million/c.mm. Iron 
was then given intravenously (200 mgra. twice a week to a 
total of 2,600 mgm,) An immediate response resulted, and 
the haemoglobin rose steadily to 96$. Malabsorption of iron 
cannot therefore be discounted as possibly being of import­
ance, but in considering the whole group of cases, there 
are other factors which seem to deserve more attention than 
is often given to them.
The high curves obtained in the majority of the 
gastro-enterostomy patients are of the type already demon­
strated in chronic post-haemorrhagic anaemia. In patientswLth
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a gastro-enterostomy, there is the possibility that healing 
of the original ulcer in a proportion of cases is incomplete. 
Moreover, a stomal ulcer may develop and this does not always 
produce symptoms. It might consequently be said that patients 
with gastro-enterostomy form a selected group in which to 
watch for the development of haemoglobin deficiency anaemia 
due to chronic haemorrhage. Only two of the present group 
showed a positive faecal occult blood, but a negative test 
when the patient is investigated does not eliminate the 
possibility that bleeding may previously have been present.
Many peptic ulcer patients have had impressed upon 
them the necessity of taking a ’bland diet”. Left to the 
patient, interpretation of this advice often results in a 
most inadequate dietary regime, in which deficiency of iron 
is one of the features. Assessment of the dietary intake 
of patients at home is notoriously difficult, but there is 
no doubt that 5 of the present group were existing on a 
completely inadequate food intake in which satisfactory 
sources of iron were few.
The conception of malabsorption of iron as a cause 
of anaemia after gastro-enterostomy should therefore prob­
ably not be allowed to take precedence over the more 
common causes of iron deficiency anaemia such as chronic 
haemorrhage and deficient iron intake. In this series, as
in the simple iron deficiency anaemias, even patients 
with flat curves responded to oral treatment under 
hospital supervision. (The one who received intravenous 
iron and on whom a test was not performed was not hospit­
alized, )
Oral absorption curves in pernicious anaemia.
Absorption curves were performed in 5 classic cases 
of untreated pernicious anaemia in whom the initial serum 
iron levels were high. During the first two hours, a rise 
was demonstrable, (Fig,35), but this was the only group 
which later showed a fall to below the fasting serum iron 
concentration. It has already been shown that removal of 
iron once in the blood stream tends to be delayed in rate 
in pernicious anaemia. It is certainly not accelerated, 
so that the unusual fall in oral curves cannot be accounted 
for by the rate of disappearance of iron from the blood.
The fall probably indicates that serum iron levels are not 
being sufficiently influenced by the iron absorbed to over­
come the effect of the spontaneous daily fluctuation in 
serum iron which at high levels is sometimes associated 
with a drop towards evening. The initial rise indicates 
that some iron is being absorbed, even although maturation 
of erythrocytes is arrested and iron requirements for haemo­
globin formation correspondingly small. It should be noted
that the greatest height is not actually less than in some 










Pig. 35. Oral iron absorption curves in pernicious
anaemia.
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Confirmation that some iron is absorbed in patients with 
untreated pernicious anaemia but not immediately made use 
of is found in the work of Dubach et al. (1946), who show 
that radioactive iron given orally appears only in very 
small amounts in the circulating red cells of untreated 
cases, but once remission is induced, radioactive iron 
rises to as much as 20% in the peripheral blood without 
any further oral dose being given. This indicates that 
even though the tissues probably contain an excess of stored 
iron, a proportion of orally administered iron is still ab­
sorbed, and is used later in haemoglobin formation.
Analysis of oral curves in anaemia associated with toxic, 
Infective and neoplastic disease. Iron lack as an aettol- 
ogical factor in the production of anaemia of infection and 
related refractory normochromic anaemias has been exhaustively 
investigated, and in spite of consistently negative findings, 
it is still often postulated. The fact that most such 
anaemias are now being proved refractory to parenteral as 
well as to oral iron is strengthening the evidence against 
iron deficiency in itself being a cause of the anaemia.
The fate of iron in such states remains imperfectly under­
stood. Block to intestinal iron absorption or block to 
utilisation in the marrow are postulated. The small recovery 
of radio-active material in erythrocytes following administra­
tion of radio-active iron orally, as described by Finch et al.
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(1949) and Dubaeh et al. (1946) cannot be regarded as 
necessarily indicative of poor iron absorption in view 
of the fact that all absorbed iron is not always immed­
iately utilised. Dubaeh et al.(1950), by radio-active 
iron balance experiments used in conjunction with estimations 
of iron utilisation, found absorption of 52% and 2>2% of orally 
administered iron in 2 cases of lymphadenoma and 20% in a 
patient with haen^oehromatosis. On the other hand, in animal 
experiments> Gubler et al.(1950), found that the total iron 
content of infected rats fed on iron-enriched diet was less 
than the iron content of normal rats fed the same diet for 
a similar period. Whether their experimental findings can 
be applied to humans is doubtful.
Oral iron absorption tests were applied to the 
problem in the present work. Cases investigated included 
patients with uraemia, rheumatoid arthritis, empyema, 
pyelitis, pneumonia, lymphadenoma, chronic leukaemia and 
bronchial carcinoma. No cases with any evidence of blood 
loss were included. The anaemia was of normochromic normo­
blastic type in all cases except two, in which it was 
slightly hypochromic. The curves obtained were of a pattern 
comparable to normal in each group (Pigs.36,a, b, and c.)
Since absorption of iron was not depressed, as 





















Fig. 36. Oral iron absorption curves in refractory 
normoblastic anaemia associated with - 
a. toxic diseases, b. infectious, c. neoplastic diseases
of iron is a primary factor in production of the anaemia.
The intravenous tests showed a rapid rate of disappearance 
of iron from the plasma, the iron being retained within the 
body. It therefore appears that blockage in iron utiliza­
tion in these anaemias occurs at the site of blood formation 
and not at the level of intestinal absorption. Histological 
evidence of marrow iron accumulation will be presented in 
the next section, and Pirrie, working in this Department, 
has found excessive iron stores in the organs of such 
patients on direct estimation of their iron content.
Prom a practical point of view, it is of importance 
to note that defective absorption of iron as compared with 
normal has not been demonstrated. Excessive absorption, 
such as was present in the majority of cases of simple iron 
deficiency, was not, however, encountered. The lower curves 
may therefore be regarded as indicative of potential refrac­
toriness to oral iron therapy, but not pathognomic of such 
a state, because the few cases of simple iron deficiency 
with similar curves responded subsequently to routine 
therapy.
Summary: Absorption of iron from the alimentary tract
has been studied by means of serial serum iron determinations 
after oral iron loading in cases of chronic iron deficiency 
anaemia, gastro-enterostomy associated with hypochromic
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anaemia, pernicious anaemia and refractory normoblastic 
anaemia associated with toxic, infective and neoplastic 
disease. The results have been discussed in relation to 
my investigations by means of intravenous iron disappear­
ance tests. Greatly enhanced iron absorption is evident 
in most cases of chronic iron deficiency, but in a propor­
tion of cases iron absorption is relatively poor. The 
flattest curves are recorded in cases of idiopathic nature 
and since the degree of absorption could not be related to 
the rate of disappearance of iron from the blood, to age, 
sex, or utilisation, or to the occurrence of achlorhydria, 
the possibility must be considered that some other local 
abnormality accounts for the defective absorption. In 
patients with gastro-enterostomy, the curves obtained 
suggest that occult haemorrhage and deficient iron intake 
must be regarded as of no less importance than malabsorption 
in accounting for hypochromic anaemia. In pernicious anaemia 
and in refractory normoblastic anaemia, iron requirement for 
haeraoglobination is minimal. Nevertheless, iron absorption 
remains equal to normal. In the refractory group, this 
finding, In association with the rapid disappearance of 
iron from the blood stream previously demonstrated, suggests 
an active accumulation of iron within the body. Refractori­
ness to oral Iron treatment of a normoblastic anaemia, 
cannot definitely be anticipated from the type of absorption
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curve obtained; flatter curves than normal were never 
encountered, and cases of idiopathic anaemia with relatively 
low curves responded to oral treatment. Performance 
of an intravenous test is of no additional value because the 
disappearance rate in both these types of anaemia is rapid.
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PART VIII,
HISTOLOGICAL IRON IN STERNAL PUNCTURE MATERIAL.
There can be no doubt both, from the foregoing and 
from other published work that the amount of iron absorbed 
from the alimentary tract varies in different forms of 
anaemiai that iron once in the blood is limited in its 
maximum concentration by the quantity of iron-combining 
protein present, and that the disappearance of iron from 
the plasma is affected by the nature of the anaemia. The 
present conception of iron metabolism infers that the ex­
isting body stores of iron play an important role in the 
control of these processes. The significance of storage 
iron and its influence on iron metabolism has not yet, 
however, been satisfactorily evaluated, probably largely 
because of difficulties in its measurement and uncertainty 
as to what it actually constitutes. In the present work 
a study was made of depot iron in relation to iron assimi­
lation. Histological iron in marrow biopsy smears and 
sections was used as the index of iron storage. Interpret­
ation of the findings obtained is dependent upon an under­
standing of the nature and relationship of the storage 
compounds haemosiderin and ferritin, and upon a knowledge 
of their functions and of the mechanisms liable to affect 
the site or the extent of storage.
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Haemosiderin: The terra haemosiderin does not denote a
specific chemical substance; it is merely descriptive of 
a granular pigment seen in unstained histological prepara­
tions as golden granules and giving the histochemical re­
actions of iron when stained. It is an iron-protein com­
plex of varying form, but whether all its forms are avail­
able to the organism for haemoglobin synthesis is doubtful. 
The pigment is probably chiefly formed as an intermediate 
product in the breakdown of haemoglobin and as such appears 
in the reticulo-endothelial cells where effete erythrocytes 
are ingested. It is possible that it also develops intra- 
eellularly in degenerating cells. Gillman and Gillman 
(1944 and 1945) In a study of liver biopsy specimens from 
200 patients with pellagra observed the development and 
increase of haemosiderin in liver cells concurrent with the 
disintegration and disappearance of mitochondria. The know­
ledge that mitochondria contain; lipo-protein and iron, the 
constituents of haemosiderin, suggested that the haemosiderin 
became formed within the cells.
Ferritin: Ferritin is a well defined iron-protein complex
which occurs as an iron storage compound particularly in 
liver, spleen and bone marrow. It cannot be demonstrated 
histologically but can be isolated in crystallized form, 
the crystals being specific for different species. It has
never been synthesised in vitro. In vivo, its synthesis 
is probably catalyzed by specific substances, and it is 
possible that derangement of the enzymatic mechanism respon­
sible may account for some types of anaemia. (Laufberger, 
1937; Granlck, 1946; Micbaelis, 1947). Its storage function 
was established by Hahn. (1943,b) when he showed that in­
jected radio-active iron was recoverable shortly after its 
administration in molecules of ferritin isolated from liver 
and spleen. About 20$ of the injected Iron is converted 
into ferritin in two hours (Granick and Hahn, 1944).
Storage ferritin is the same compound as is demonstrable 
in the gastro-intestinal mucosa In relation to iron absorp­
tion. Its absence from the serum indicates that it is not 
a compound likely to be concerned In iron transport.
(Granick, 1948). Its protein component, apoferritin, al­
though crystallizable, has also never been isolated in vivo 
either from plasma or from storage organs. Evidence indi­
cates that it is formed only as required for ferritin syn­
thesis and disappears again when iron has to be released 
for transport or for haemoglobin formation.
Relationship and functions of ferritin and, haemosiderin: The 
chemical nature of the two compounds is similar- (Granick, 
1946), and haemosiderin may actually represent a condensation 
or clustering of ferritin molecules. (Granick, 1949). Both
are iron-protein complexes and both occur intracellularly 
in similar sites in the body. That they are important fac­
tors in connection with iron storage is indicated by their 
occurrence in the recognised iron depots, (liver, spleen 
and bone marrow), and by the very high iron content of 
ferritin, (23%)» It is general opinion that there are at 
present no justifiable grounds for their functional differ­
entiation from the standpoint of storage. According to 
Pinch et al.(1950) each increases in the tissues in the 
presence of excess iron, and each becomes depleted when 
iron is required for erythrogenesis« He quotes unpublished 
data of his own as supporting the observations of Sandberg 
et al. (1942) that storage iron of both types becomes in­
creased if there is reduction in the circulating red cell 
mass due to any other cause than haemorrhage or iron defic­
iency. That both forms are normally available for haemo­
globin production is Indicated by the complete disappearance 
of haemosiderin from histological specimens and the reduc­
tion to minimal amounts of chemically-estimated iron In the 
livers of dogs which have been bled. It is possible that over 
filling of cells with iron may impair their function and con­
sequently their ability to liberate stored Iron. In this 
way, it may happen that iron is not available for erythro- 
poiesis even although stored in excess. The similarities 
between haemosiderin and ferritin have to be accepted
meantime in an investigation of the function of storage 
iron but differences must not be forgotten; for instance, 
in aplastic anaemia, consistently less siderosis is pro­
duced than in haemolytic anaemia, even although the chemi­
cal iron content of depot organs may be similar.
Site and extent of iron storage; Iron is widely distrib­
uted in the body, but for convenience may be considered 
as occurring in two main depots, the reticulo-endothelial 
system and the parenchymal cells, the liver far exceeding 
other parenchymal tissues in its storage capacity. The 
iron of the retiaiLo-endothelial system comprises chiefly 
iron liberated from extravascular destruction of red cells 
and any colloidal iron given intravenously, the former 
being mainly localised in the spleen and the latter in the 
liver and bone marrow. Parenchymal iron represents 
chiefly that which has been stored following alimentary 
assimilation, or deposited after intravenous administration 
of simple iron salts. Both reticulo-endothelial and paren­
chymal iron reach their greatest concentration in the liver. 
Significant amounts of iron are demonstrable in the cells of 
the renal tubules after intravascular haemolysis. This is 
explained by reabsorption of iron liberated from local dis­
integration of haemoglobin which has exceeded the renal 
threshold and entered the tubules. Focal haemosiderosis
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can occur In any organ or tissue where blood is extra- 
vasated locally and decomposed; it occurs in the neigh­
bouring macrophages and lymph glands.
The amount of iron stored may be influenced in two 
ways. Because the body is relatively unable to excrete 
iron, redistribution of the normal body iron content may 
become necessary if the red cell mass is reduced by any­
thing other than haemorrhage or iron deficiency; the 
storage iron compartment then increases proportionately to 
the decrease in blood iron (Panger et al, Unpublished - 
quoted by Finch et al# 1950). This is in contrast to the 
absolute increase in body iron which can follow excessive 
iron absorption or parenteral iron administration. If the 
l!mucosal block” theory as described by Granick (1946) were 
fullrproof, unwanted iron should not pass through the in­
testinal mucosa. Nevertheless, excessive storage does occur 
under certain circumstances. It has been demonstrated when 
pyridoxin is deficient, when phosphate intake is extremely 
low, after ligation of the pancreatic ducts, in haemochroma- 
tosis, and probably in some refractory anaemic states. The 
ultimate distribution of iron stored in the body is similar 
whatever its initial disposition, (Poison, 1933; Cappell., 1930) 
and is localised mainly in the liver.
A biopsy sample of sternal marrow affords a very
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small glimpse of this enormous and complex storage 
system and represents only reticulo-endothelial iron. 
Nevertheless, examination of such specimens is the 
only means of gaining some direct insight into the state 
of storage during life. Biopsy of the liver, the most 
important storehouse, is feasible, but is too hazardous 
a procedure to be performed routinely for research pur­
poses. finch (1948) produced evidence that stainable 
marrow iron is actually roughly proportional to the expected 
total body stores. It is usually absent in iron deficiency, 
present in small amounts in health, and increased excess­
ively in haemochromatosis, while in different forms of 
anaemia, varying intermediate amounts are seen. Conse­
quently, provided the patient has not received blood trans­
fusion or parenteral iron, histological marrow iron can be 
regarded as an index of the storage component of iron meta­
bolism within the organism.
Material examined: Smears and sections were made from
marrow granules obtained by sternal puncture. Demonstration 
of iron was carried out by staining the preparations for 
30 minutes with a mixture of equal parts of freshly - 
prepared 2fo potassium ferrocyanide solution and 2ft hydro­
chloric acid. After washing in distilled water, they were 
counterstained with 1 fo neutral red for 15 minutes. In
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Fig. 37. Marrow section of sternal puncture 
material showing moderately light infiltration
with iron.




Fig. 38. Marrow section of sternal puncture 
material showing heavy infiltration with iron. 
Prussian blue reaction counter-stained with
methyl red.
Carbro prints from Ektachrome transparencies.
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Pig. 39. Marrow section of sternal puncture 
material showing infiltration with iron. 
Prussian blue reaction counter-stained with
methyl red.
xqoo
Fig.40. Group of iron-positive granules in_a 
smear preparation of sternal puncture material. 
Prussian "blue reaction counter-stained with
methyl red.
Carbro prints from Ektachrome transparencies.
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each instance 2 or 3 marrow smears and one section were 
examined for stained iron, so that any inaccuracies due to 
irregular dispersal of the iron might be minimised* The 
amount of iron present varied considerably from case to case, 
but there was satisfactory agreement between the amount 
demonstrable in marrow smears and the amount identified in 
the sections* The method of preparation did not lend itself 
to demonstration of histological detail but the iron itself 
was readily distinguishable as Prussian blue granules of 
variable coarseness. In the smears most of the iron was 
apparently lying free in the matrix, but here and there 
aggregations of granules round a nucleus indicated an 
intracellular origin*
The cases were classified arbitrarily into 5 grades 
according to the amount of iron seen, grade 1 representing 
absence of iron and grades 2 to 5 increasing amounts* Actual 
classification was made on an overall assessment of the 
amount of iron present but Pigs* 37 and 38 show representative 
fields from heavily and lightly infiltrated preparations.
The punctate nature of distribution is more easily 
distinguishable in Pig. 39. The granular nature of the 
deposit was most readily seen in the smears and an example of a 
collection/
of coarse iron positive granules is shown in Pig. 40. 
Preparations from 15 normal subjects and from 102 
patients with anaemia were examined. The results 
obtained are presented in Table 23.
Besults in relation to expected iron reserves:
The amount of iron demonstrable conforms 
to the proportions which could be expected in the 
various types of cases investigated. In normal
people, only small amounts are found; in iron 
deficiency, there is consistent absence of iron; 
in pernicious anaemia and haemolytic anaemia, there 
is an increase in iron in a quarter and a third of 
the patients respectively. This is compatible 
with exhausted reserves in iron deficiency and 
with a redistribution of the body iron due to 
reduction in the red cell mass in pernicious anaemia 
and haemolytic anaemia. Of the four patients with 
pernicious anaemia in whom negative results were 
obtained for marrow iron, 2 were among those 
previously presented as having an M.C.H.C. below 
normal and low serum iron concentrations. (Table 11 
Nos. 5 and 10). The two others had low serum iron 
concentrations but a normal M.C.H.C.
Table 23» Stainable marrow iron graded according to 
the amounts present.
Condition
r—--- ---  ----
Grade * Total no.
1 2 3 4 5
Normals 3 5 7 - - 15
Anaemia of 
toxic states 2 — 3 2 — 7
Anaemia of 
infection 2 3 2 2 3 12
Anaemia of 
neoplastic 
disease 5 3 7 5 2 22
Iron
deficiency 21 - - - - 21
Pernicious
anaemia 4 3 5 3 1 16
Aplastic
anaemia — — 1 — — 1
Cirrhosis of 
liver 1 1 — — - 2
Haemolytic
anaemia - - 2 2 2 6
* Grade 1 = absence of iron
Grades 2 to 5 = increasing amounts of iron
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The combined findings suggest concurrent existence of 
a moderate degree of iron deficiency in these patients*
In the refractory normoblastic anaemias, the marrow iron 
deposit was again in excess of normal, and in fact, often 
appeared greater than was to be expected from the degree of 
anaemia*
Marrow siderosis in relation to transport, absorption and 
assimilation of iron: The quantity of iron present in the
depots does not appear to be entirely responsible for the 
concentration at which the circulating serum iron is main­
tained* Exhausted stores in iron deficiency are certainly 
associated with very low levels of transport iron, and in­
creased stores in pernicious anaemia with relatively high 
levels, but in the refractory anaemia group, an increase in 
storage exists in conjunction with reduction in transport 
iron to about half normal levels*
Existing stores also cannot be wholly responsible 
for the amount of iron assimilated* In the case of iron 
deficiency anaemia, alimentary absorption of iron has been 
shown to be greatly enhanced in the great majority of cases 
and the rate of disappearance of iron from the blood always 
accelerated* In pernicious anaemia, both these functions 
are depressed below normal. These findings might have been 
attributed purely to decreased and increased stores respect­
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ively, but in the refractory normoblastic anaemias 
existence of excessive storage is accompanied by an 
alimentary absorption of iron equal to normal, and an 
increase in the rate of disappearance of iron from the 
blood. Prom a histological study alone one cannot be 
dogmatic that the siderosis recorded represents an 
absolute increase in the body iron but the work of Pirrie, 
(personal communication) indicates that the amount of depot 
iron in patients with infections or carcinoma is in fact 
significantly increased beyond that which can be accounted 
for by redistribution of iron already in the body. Accumu­
lation of depot iron in these patients would therefore 
appear to be an active rather than a passive process as it 
continues even after the total iron has reached average 
normal limits.
Consideration of findings in relation to Granick1 s t!mucosal 
block” theory: In its simplest form, Granickfs theory
states that iron is absorbed from the intestine only until 
the mucosal cells become saturated and is passed on to the 
serum when the iron concentration there is diminished, this 
concentration being largely determined by the body iron 
requirement. The amount of iron absorbed is therefore 
ultimately dependent upon the quantity of iron stored, and 
is theoretically negligible when stores are replete. The
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present findings in iron deficiency anaemia and in 
pernicious anaemia are essentially in keeping with such 
a hypothesis, hut there is accumulating evidence that the 
theory is not water-tight. In this investigation the con­
tinued iron absorption and the increase in the rate of 
disappearance of iron from the serum in spite of well- 
filled stores in patients with refractory anaemia suggest 
that under certain circumstances the absorptive mechanism 
may be modified. The work of other investigators also indi­
cates that the !,mucosal block11 must at times be overcome* 
Balfour et al. (1942) described a case of leukaemia in which 
orally- administered radio-active iron was never demonstrable 
in the haemoglobin but was isolated from the liver and 
spleen at autopsy a few months later. Dubach et al. (1948) 
after giving radio-active iron orally to a patient with 
pernicious anaemia recovered only minimal amounts in the 
haemoglobin before treatment, but after administration of 
liver accounted for 20% of it. In two patients with Hodgkin’s 
disease and refractory anaemia, they recorded absorption of 
52'$ and 32$ of orally administered doses. In animals, 
pyridoxin deficiency has led to iron absorption of suffic­
ient degree to cause haemochromatosis (Cartwright et al.
1949; Gubler et al. 1949), and reduction in the free phos­
phate content of the diet has caused similar changes (Day
157
and Stein, 1938; Kinney, 1949; Hegsted et al. 1949).
Excessive iron accumulation was recorded by Taylor et al.
(1931 and 1935) after ligature of the pancreatic duct in 
cats, and Pinch et al. (1950) confirmed this in dogs. In 
humans, Gillman and Gillman (1945) observed hepatic sider­
osis in African pellagrins, studied by liver biopsy. In 
normal men, prolonged administration of iron has been 
claimed to cause an increase in haemoglobin but of temporary 
duration (Fowler & Barer, 1941), while iron accumulation in 
the organs of Bantu races has been shown attributable simply 
to a prolonged high dietary iron intake resulting from 
constant cooking of food in iron utensils (Walker and Arvidsson, 
1950).
Stainable marrow iron as a guide to intravenous iron therapy:
It is inadvisable to give parenteral iron indiscriminately in 
view of the fact that the body has difficulty in getting rid 
of unwanted iron, and although never proved experimentally, 
the occurrence of fibrosis in the iron storage organs in 
haemochromatosis raises the possibility that iron accumulation 
can lead to fibrous tissue formation. In iron deficiency 
anaemia, iron was consistently absent from the marrow and iron 
was required as treatment; in pernicious anaemia, iron was 
mostly demonstrable in the marrow, and iron was not indi­
cated for treatment. Consequently it seems worth while to 
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from the aspect of stainable marrow iron as an indication 
or otherwise for parenteral iron therapy. In so doing, 
three facts have to be borne in mind. Firstly, a marrow 
which is negative for haemosiderin may nevertheless con­
tain the non-stainable ferritin iron. Secondly, a 
considerable amount of haemosiderin iron must be present 
in the tissues before it is demonstrable histologically 
(in the case of liver, 10 - 12 mg. per 100 g. wet 
tissue). Thirdly, haemosiderin, even although demonstrated, 
is not necessarily available for haemoglobin synthesis.
Eighteen of the patients with refractory normoblastic 
anaemia received full courses of iron intravenously.
Haematological data are given in Table 24. The results 
of therapy in this small series cannot be considered 
conclusive but only in patients 1 and 15 was there any 
significant rise in haemoglobin and this was slight. In
the latter, the patient's general condition also improved, 
making it impossible to say whether the haemoglobin rise 
was attributable to therapy or to recovery from the 
primary disease. As 13 of the 18 patients had iron 
present in the marrow, it is probably justifiable to 
suggest that in the presence of histological iron in the 
marrow a response to iron, given either orally or parenterally 
is unlikely. In the absence of marrow siderosis administra­
tion of parenteral iron is indicated if oral treatment has
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failed, but cannot be expected to be necessarily beneficial.
It is quite possible that in the latter cases there is in 
fact no iron lack in the marrow but that such metal as 
is present is in the form of ferritin. Kulns et al.
(1950) and Slack and Wilkinson (1949) were equally unsuccessful 
in correcting similar types of refractory anaemia by 
intravenous iron administration. On the other hand,
Sinclair and Duthie (1949) claimed significant but 
long delayed haematological improvement in patients with 
rheumatoid arthritis and anaemia, when iron was given 
intravenously over several weeks. The fall in blood 
sedimentation rate in their patients who '’responded” 
makes it difficult to exclude general clinical improvement 
as the actual basis for the haemoglobin increase.
On the whole, if iron is given intravenously there 
seems little justification for continuing it in massive 
doses over a long period if no rise in haemoglobin is 
occurring. In simple iron deficiency anaemia the
beneficial effect of intravenous iron is immediate and 
dramatic. In refractory anaemias of either normochromic 
or hypochromic type there is no reason to believe that 
excessive parenteral administration of iron will be 
effective where normal dosage fails. Indeed, the case 
of a man with cirrhosis of the liver and hypochromic 
anaemia which was followed by the writer from 1948 to 
1950 provides a clear illustration that tremendous
I6 'I
accumulation of iron can occur at the actual site of 
blood formation and be ineffective, even in the presence 
of hypochromia and an active marrow, if the iron is being 
supplied to a haemopoietic system which is incapable of 
using it.
Case: The patient, a man aged 72 years, had been known
to suffer from cirrhosis of the liver for 7-8 years. The 
liver extended to the umbilicus, and had a granul&r 
surface. The spleen was not palpable. There was no 
evidence of haemochromatosis. General ill health was 
associated with anaemia of haemoglobin deficiency type.
The anaemia resisted all forms of oral iron therapy 
and in 1946 was of sufficient severity to necessitate blood 
transfusion. A prolonged course of intravenous iron 
was given subsequently by his own doctor, but the haemoglobin 
level remained unaffected. In 1948, examination of the 
sternal marrow revealed abundant stainable iron and unusually 
active normoblastic erythropoiesis (Pig. 41). Blood 
transfusion had to be repeated. In view of the liver 
damage, choline (5 g./day) and vitamin E (400 mg./day) 
were recommended in addition to oral liver and anahaemin 
which had been given for 4 years. The administration of 
choline and vitamin E was followed by regeneration of the 
haemoglobin from 40$ toi76$ without further iron being given.
Fig. 41. Marrow smear from case of cirrhosis of 
the liver after intravenous iron administration 
showing dense deposition of iron which obscures 
histological detail.
Prussian blue reaction counter-stained with methyl red
Carbro print from Ektachrome transparency.
Subsequent examination of the marrow in 1949 and again 
in 1950 still showed enormous amounts of iron present. 
Towards the end of 1950 the patient's general health 
declined, the liver became larger, the spleen just 
palpable, and the haemoglobin began to fall in spite 
of continued treatment.
Improvement of the blood levels in this patient 
must be related to the administration of choline and 
vitamin E, without which iron had been ineffective in 
overcoming the haemoglobin deficiency anaemia . The 
case supplies evidence that a marrow smear laden with 
haemosiderin is indicative that further iron administrati 
either orally or parenterally is likely to prove useless 
if the basic disturbance is not first corrected. 
Conclusions.
Stainable iron in sternal puncture specimens is 
approximately representative of the body's storage iron 
reserve. It is consistently absent in chronic 
hypochromic anaemia and its absence in a few cases of' 
pernicious anaemia can be accounted for by a tendency 
to concurrent haemoglobin deficiency. An excessive 
amount in refractory normoblastic anaemias increases 
evidence already available that such anaemias are not 
primarily the result of iron lack. Actual haemoglobin
deficiency may persist in the face of large iron reserves 
in the marrow, if the fundamental illness remains uncorrected 
In similar cases rapid disappearance of iron from the 
plasma has already been demonstrated, and also alimentary 
absorption of iron in amounts equal to normal. The cause 
for the rapid diversion of iron and its accumulation in 
the marrow is obscure, but the deviation cannot be made 
good by intravenous iron administration.
Absorption of iron in the presence of replete body 
stores makes Granick's "mucosal block" theory open to 
question. Exhausted stores, such as are demonstrable in 
chronic iron deficiency anaemia may be responsible for 
promoting the very high absorption levels characteristic 
of this group, but well-filled stores do not appear to 
suppress absorption below normal.
As a guide to the need for intravenous iron therapy, 
histological iron in the marrow is of definite but limited 
value. The fact that it is present and even excessive 
in a considerable proportion of cases of anaemia associated 
with toxic, infective, and neoplastic disease and that this 
anaemia is unaltered by parenteral iron administration 
indicates that parenteral iron is unlikely to be of any 
benefit if the marrow iron is positive.. A negative 
result for histological iron does not, however, mean an 
assured response to iron even when this is given intravenously
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Summary: The nature and distribution in the body of
the iron storage compounds haemosiderin and ferritin is 
discussed and evidence for regarding them as functionally 
similar is described. Histological iron in the marrow 
is found to be approximately representative of expected 
body stores. In iron deficiency anaemia the depleted 
stores probably influence the rate at which iron 
disappears from the blood, and the amount of iron which 
is absorbed from the intestine. In the refractory 
normoblastic anaemias associated with toxic, infective, 
and neoplastic disease iron reserves are considerable 
yet normal alimentary iron absorption occurs. In view 
of this and of the increased rate of disappearance of 
iron from the serum in these patients it appears that 
Granick1 s mucosal block theory may be modified under 
certain circumstances. The possibility of stainable 
marrow iron being a guide to the use of intravenous iron 
in refractory anaemias is discussed. If iron is 




GENERAL SUMMARY AND CONCLUSIONS*
The historical development of existing knowledge 
concerning iron metabolism has been reviewed* Attention is 
drawn to the discovery of iron as an element of the blood in 
1746, to the differentiation of haemoglobin and non-haemoglobin 
fractions between 1898 and 1915, and to the identification 
during the last quarter century of the non-haemoglobin iron 
as the transport iron of the body#
Prom this review it is evident that little attention 
has been given to the assessment of iron balance in the 
individual patient from a clinical point of view, an aspect 
of investigation which has gained significance since the 
introduction of an intravenous iron preparation satisfactory 
for therapeutic use*
The original observations described in this thesis 
consist essentially of serum iron estimation on human beings, 
under varying conditions, and the histo-chemical demonstration 
of iron in bone marrow material obtained by sternal puncture* 
The results and their significance are summarised under the
following headings:




(2) The serum iron in health
(3) The serum iron in disease
(4) The value of oral iron absorption and
intravenous iron disappearance tests in
conjunction with histo-chemical iron in the 
marrow
(5) Results in relation to iron metabolism
(6) Intravenous iron in therapeutics 
Reliability of selected methods for estimation
of serum iron*
There is no reason to doubt the reliability of 
Torapsett!s orthophenanthroline technique and Fitzpatrick*s 
ferricyanide technique for estimation of the serum iron 
provided scrupulous precautions are taken to avoid iron 
contamination of glassware, reagents and serum* Closely 
comparable results obtained by each method, and consistently 
low levels in' iron deficiency anaemia give reassuring proof 
that a specific iron fraction is being estimated and that 
experimental error plays little part in producing the wide 
variations recorded in health and in most other types of 
anaemia*
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The serum Iron In healths
Work published by other authors in regard to the 
serum iron level in normal people, and the influence upon it of 
sex, age, and time of day has been substantiated.
An investigation of 120 healthy individuals from 18 to 
65 years of age showed that the range of serum iron concentration 
is from 65 to 220 ug* % with an average of 123ug.$. The 
range for each sex is similar, but the average for males is 
129 ug.$, while for females it is 113 ug. Estimations made on
6 members of each sex over a period of 8 weeks, considered alone 
and in relation to published findings, indicate that this 
difference is more reasonably attributable to endocrine 
influence than to whole blood loss in women as a result of 
menstruation*
In 30 normal individuals followed during twenty-four 
hours it is evident that diurnal fluctuation in serum iron 
concentration occurs, this fluctuation having an average 
value of 25 ug.$. A true cyclic pattern is not established 
statistically. Prom the present work the fluctuation cannot 
be related to the taking of meals, and from investigation of 
the literature convincing evidence is still lacking for the 
claims that liver metabolism and autonomic activity play an 
important role in serum iron control.
The influence of age is difficult to dissociate 
from changes due to sex, but a definite reduction in serum
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iron with advancing years in males of this series suggests 
that old age is accompanied by a diminution in transport iron* 
The serum iron in disease:
Owing to the wide variation of the serum iron in health, 
alterations in disease have to be marked and consistent in 
order to be of significance* Single initial estimations were 
mad© on 179 cases of anaemia and, since accounts of serial 
observations in the literature are few, weekly estimations were 
continued on 52 of the cases for 8 to 12 weeks during treatment* 
Extreme hyposideraemia (serum iron less than 50 ug*$) 
is most often indicative of chronic iron deficiency anaemia, 
but cannot be considered pathognomonic of such a state since 
equally low levels sometimes occur in the refractory 
normoblastic anaemias associated with toxic,infective or 
neoplastic disease, even when the anaemia is normochromic 
and there is no evidence of blood loss* On the whole, levels 
in the latter group are slightly higher and sometimes within 
the lower limits of normal* In the case of nephritis the 
reduction Is more readily attributed to protein imbalance
than to urea retention*
Fifty-eight patients with iron deficiency were 
re-investigated after treatment* The results emphasise 
the need for prolonged iron medication after the blood count 
Is normal* Persistence of a subnormal serum iron in any
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patient whose hypochromic anaemia has responded satisfactorily 
to Iron is probably indicative of an occult complicating factor.
The hyposideraemia of chronic disease Is, like the 
anaemia, extremely intractible to iron therapy even when this 
Is given parenterally* Amongst infections, Infective hepatitis 
is exceptional in sometimes producing high serum iron levels, 
this being distinctive from the normal levels in obstructive 
jaundice*
In pernicious anaemia, a high average serum iron 
(152 ug. %) in 34 patients examined Is in agreement with 
published results. Occasional low values in the group can 
be accounted for by minor degrees of concurrent iron deficiency 
as indicated by absence of stainable iron in the marrow and 
subnormal mean corpuscular haemoglobin concentration. A 
sharp fall in serum iron concentration after giving liver 
confirms previous accounts of this finding*
Abnormally high serum iron levels are usually the 
result of severe haemolysis, but it is possible that an 
abnormality of the serum globulin may also lead to a high 
serum iron level*
The value of oral iron absorption and Intravenous iron 
disappearance tests in conjunction with histological iron
in the marrow.
The value of oral iron absorption and intravenous 
iron disappearance tests in clinical work has not previously
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been exhaustively explored* In the course of the present 
investigations 85 oral tests and 77 intravenous tests were 
carried out* Both types of test were found to be practicable 
procedures for routine use* For oral tests a relatively 
large dose of iron is required before consistent results in 
individual subjects are procured* A dose of 45 gr* of ferric 
ammonium citrate is well tolerated and satisfactory curves 
are obtained by estimation of the serum iron at 2, 4, and 7 
hours after its administration* For intravenous tests, 100 mg* 
of saccharated iron oxide in the form of HIvironn is satisfact­
ory as a test substance, and the serum iron level 5 minutes after 
its injection can be used as a guide to serum iron-combining 
capacity, and during the next 7 hours for assessing the rate 
of disappearance of iron from the blood* A constant 
experimental error occurs in the estimation of colloidal iron 
mixed with serum, but the error is sufficiently consistent 
to allow of comparative studies being made*
Analysis of the amount of demonstrable iron in sternal 
puncture specimens of marrow obtained in 102 cases was used 
to supplement the information from oral and intravenous tests* 
From a diagnostic point of view in clinical work it can 
be concluded that the intravenous disappearance test adds 
little information to that which can be obtained by the
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simpler oral absorption test alone* For the oral test an 
arbitrary level of 100 ug*$ may be set for the maximum 
reading* A rise in excess of this amount almost certainly 
indicates iron deficiency and an assured satisfactory response 
to oral iron therapy* Lesser absoprtion is not definitely 
indicative of refractoriness to iron, because although 
characteristic of refractory normoblastic anaemia, it is also 
met with in a proportion of simple iron deficiency cases 
who subsequently respond normally to routine oral treatment • 
Histochemical demonstration of iron in the marrow is of 
particular value in these cases since a positive result 
indicates that administration of iron either orally or 
intravenously is unlikely to be effective, while a negative 
result warrants a trial of intravenous iron if oral treatment 
fails#
No opportunity was obtained of investigating patients 
with uncomplicated iron deficiency anaemia, whose anaemia 
proved refractory to oral iron but amenable to intravenous 
iron, because such cases were not encountered during the 
course of treating 189 patients with simple iron deficiency* 
The view of Wilkinson & Slack (1949) and Crawley (1951) that 
such cases occur and are due to intestinal malabsorption 
could not therefore be corroborated*
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Results in relation to iron metabolism*
The data obtained in this investigation have also been 
discussed in relation to their significance in the general 
problem of iron metabolism, although the need for caution 
in drawing sweeping conclusions has been stressed, because 
the oral iron was given in massive dosage, the intravenous 
iron was in colloidal form, and the histochemical preparations 
demonstrated only haemosiderin* It appears justifiable to 
conclude, however, that when body stores are depleted of iron 
and there is simple haemoglobin deficiency anaemia, the amount 
of iron absorbed from a single dose given orally is usually 
greatly in excess of normal* When stores are replete there is 
no evidence that absorption of iron can be depressed below 
normal* '^here is a possibility that certain patients with 
simple iron deficiency cannot readily increase the proportion 
of iron absorbed from massive doses, but since all such patients 
showed a satisfactory response to oral iron treatment it is 
difficult to accept malabsorption of iron as a basic aetiological 
factor In their anaemia without more convincing experimental 
evidence* Even in hypochromic anaemia following gastro- , 
enterostomy, the possibility that poor iron absorption plays a 
significant role in production of the anaemia could not readily 
be substantiated*
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In the refractory normoblastic anaemias, normal 
absorption of iron from the gut, rapid diversion of iron 
from the plasma, and a tendency towards accumulation of iron 
in the depots has been demonstrated* The site of interuption 
of blood formation would therefore appear to be the marrow, and 
even in the presence of hypochromia, excessive iron intravenously 
fails to force the block* Accumulated iron is probably available 
at a later date for haemoglobin formation if the basic illness 
can be corrected*
The amount of iron apparently absorbed from the gut 
is independent of the serum iron-binding capacity and of 
the serum iron concentration, and cannot be related to age, 
sex, gastric acidity or haemoglobin level. It could also 
not be related to the rate of disappearance of iron from the 
plasma, but this problem and the question of rate of utilization 
of iron require further investigation*
The significance of these views, in relation to 
those published by other workers in this field has been 
discussed*
Intravenous iron in therapeutics*
In the cases of anaemia investigated there was little 
evidence that intravenous iron is superior to oral iron in 
routine treatment. Adequate oral iron dosage given for long 
enough was effective in 189 patients with simple iron deficiency#
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Five of these, however, required hosjjital supervision before 
recovery was complete, and in such cases intravenous iron is 
warranted to avoid hospitalization. No case of uncomplicated 
iron deficiency refractory to oral treatment but amenable to 
intravenous iron was encountered. In a very small number of 
cases in which there is an intrinsic intestinal abnormality 
parenteral therapy may be successful when oral treatment 
fails. In respect of refractory normoblastic anaemia 
associated with toxic, infective, or neoplastic disease, 
personal experience in the use of intravenous iron was 
limited to 18 cases. The results were uniformly 
unsuccessful. Among 43 similar cases, the finding of 
excessive accumulation of iron in the marrow, increases 
evidence that further supplies of iron, however given, are 
unlikely to be utilized. There is no reason to believe 
that excessive iron given parenterally will prove beneficial.
Use of intravenous iron may occasionally be justified 
to avoid troublesome alimentary disturbance due to oral iron. 
Nevertheless, it should be remembered that although unpleasant 
side effects with MIvironH are few, their severity may 
occasionally be alarming leading to collapse and lumbar pain. 
Also, the slightest leak at the injection site causes intense 
pain, induration, and often thrombosis.
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Any beneficial effect from intravenous iron is usually 
immediate, and it is consequently unnecessary to prolong 
administration beyond a few hundred milligrams if no rise in 
haemoglobin or red cells is occurring. The late results and 
possible ill effects of accumulated iron in the body are 
relatively unknown factors in the human subject*
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